Brett W. Carter, M.D., CPE, CPPS

Peer-Reviewed Articles

1. on Thoracic EP, Gastrointestinal, Imaging AU, Brixey AG, Fung A, De Leon AD, Walker CM, Porter KK, Khatri G, Bang TJ, Batra K, Carter BW, Christensen JD, Cox CW, Davis AM, Holley AB, Kandathil A, Little BP, Madan R, Mehta P, Moore WH, Shroff GS, Uyeda JW, Nikolaidis P, Kamel IR, Chung JH. ACR Appropriateness Criteria® Sepsis. J Am Coll Radiol 21(6S):S292-S309, 2024. e-Pub 2024. PMID: 38823951.
2. Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, Sujit SJ, Lu X, Young E, Al-Tashi Q, Qureshi R, Wu CC, Carter BW, Lin SH, Lee PP, Gandhi S, Chang JY, Li R, Gensheimer MF, Wakelee HA, Neal JW, Lee HS, Cheng C, Velcheti V, Lou Y, Petranovic M, Rinsurongkawong W, Le X, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Antonoff MB, Sepesi B, Lewis J, Wistuba II, Hazle JD, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee JJ, Heymach JV, Zhang J, Wu J. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. Lancet Digit Health 5(7):e404-e420, 2023. e-Pub 2023. PMID: 37268451.
3. Strange CD, Marom EM, Ahuja J, Shroff GS, Gladish GW, Carter BW, Truong MT. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma. Adv Anat Pathol 30(4):280-291, 2023. e-Pub 2023. PMID: 36395181.
4. Altan M, Wang Y, Song J, Welsh J, Tang C, Guha-Thakurta N, Blumenschein GR, Carter BW, Wefel JS, Ghia AJ, Yeboa DN, McAleer MF, Chung C, Woodhouse KD, McGovern SL, Wang C, Kim BYS, Weinberg JS, Briere TM, Elamin YY, Le X, Cascone T, Negrao MV, Skoulidis F, Ferrarotto R, Heymach JV, Li J. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer 11(7), 2023. e-Pub 2023. PMID: 37402581.
5. Singhi EK, Mott F, Worst M, Leung CH, Lee JJ, Carter B, Presley CJ, Heymach JV, Altan M. Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non-small cell lung cancer. Oncol Lett 25(6):262, 2023. e-Pub 2023. PMID: 37216156.
6. Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, William WN, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L, Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Blumenschein G, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG, Vaporciyan AA, Lin HY, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi B. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med 29(3):593-604, 2023. e-Pub 2023. PMID: 36928818.
7. Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Jack Lee J, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J, Vokes NI. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer. Nat Commun 14(1):695, 2023. e-Pub 2023. PMID: 36755027.
8. Westin SN, Fu S, Tsimberidou A, Piha-Paul S, Akhmedzhanov F, Yilmaz B, McQuinn L, Brink AL, Gong J, Leung CH, Lin H, Hong DS, Pant S, Carter B, Jazaeri A, Gershenson D, Sood AK, Coleman RL, Shah J, Meric-Bernstam F, Naing A. Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer. Gynecol Oncol 168:76-82, 2023. e-Pub 2023. PMID: 36423446.
9. Liu Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Skoulidis F, Chang JY, Liao Z, Gomez DR, O'Reilly M, Heymach JV, Tsao AS, Lin SH. Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial. Lung Cancer 174:112-117, 2022. e-Pub 2022. PMID: 36371941.
10. Elamin YY, Robichaux JP, Carter BW, Altan M, Tran H, Gibbons DL, Heeke S, Fossella FV, Lam VK, Le X, Negrao MV, Nilsson MB, Patel A, Vijayan RSK, Cross JB, Zhang J, Byers LA, Lu C, Cascone T, Feng L, Luthra R, San Lucas FA, Mantha G, Routbort M, Blumenschein G, Tsao AS, Heymach JV. Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity. Cancer Cell 40(7):754-767.e6, 2022. e-Pub 2022. PMID: 35820397.
11. Altan M, Singhi EK, Worst M, Carter BW, Leung CH, Lee JJ, Presley CJ, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Zhang J, Gibbons DL, Vaporciyan AA, Heymach JV, Mott FE. Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer. Clin Lung Cancer 23(3):236-243, 2022. e-Pub 2022. PMID: 35216923.
12. Shroff GS, Wu CC, Ocazionez D, Carter BW, Shivaprasad A, Chai T, Supsupin EP, Truong MT, Shroff S. It's Not All in Your Head: Thoracic Manifestations of Neurologic Diseases and Disorders. Acad Radiol 29(5):736-747, 2022. e-Pub 2022. PMID: 32622741.
13. Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Zarifa A, Shah J, Milton DR, Bean S, McQuinn L, Gong J, Colen R, Carter BW, Subbiah V, Ogbonna DC, Pant S, Meric-Bernstam F, Naing A. Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs 40(2):461, 2022. e-Pub 2022. PMID: 34705134.
14. Thein KZ, Karp DD, Tsimberidou A, Gong J, Sulovic S, Shah J, Milton DR, Hong DS, Janku F, McQuinn L, Stephen BA, Colen R, Carter BW, Yap TA, Piha-Paul SA, Fu S, Meric-Bernstam F, Naing A. Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study. Invest New Drugs 40(2):290-299, 2022. e-Pub 2022. PMID: 34562230.
15. Elamin YY, Robichaux JP, Carter BW, Altan M, Gibbons DL, Fossella FV, Lam VK, Patel AB, Negrao MV, Le X, Mott FE, Zhang J, Feng L, Blumenschein G, Tsao AS, Heymach JV. Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. J Clin Oncol 40(7):702-709, 2022. e-Pub 2022. PMID: 34550757.
16. Thein KZ, Fu S, Janku F, Tsimberidou AM, Piha-Paul SA, Karp DD, Shah J, Milton DR, Gong J, Sulovic S, McQuinn L, Stephen BA, Colen RR, Carter BW, Meric-Bernstam F, Naing A. Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study. J Immunother Precis Oncol 5(1):10-12, 2022. e-Pub 2022. PMID: 35663832.
17. Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Fu S, Subbiah V, Hong DS, Yap TA, Shah J, Milton DR, McQuinn L, Gong J, Tran Y, Carter BW, Colen R, Meric-Bernstam F, Naing A. Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors. Exp Hematol Oncol 10(1):59, 2021. e-Pub 2021. PMID: 34965890.
18. Thoracic Imaging: EPO, Hobbs SB, Chung JH, Walker CM, Bang TJ, Carter BW, Christensen JD, Danoff SK, Kandathil A, Madan R, Moore WH, Shah SD, Kanne JP. ACR Appropriateness Criteria® Diffuse Lung Disease 18(11S):S320-S329, 2021. e-Pub 2021. PMID: 34794591.
19. Thoracic Imaging EPO, Stowell JT, Walker CM, Chung JH, Bang TJ, Carter BW, Christensen JD, Donnelly EF, Hanna TN, Hobbs SB, Johnson BD, Kandathil A, Lo BM, Madan R, Majercik S, Moore WH, Kanne JP. ACR Appropriateness Criteria® Nontraumatic Chest Wall Pain 18(11S):S394-S405, 2021. e-Pub 2021. PMID: 34794596.
20. Rao SH, Virarkar M, Yang WT, Carter BW, Liu TA, Piwnica-Worms D, Bhosale PR. Streamlining the Quantitative Metrics Workflow at a Comprehensive Cancer Center. Acad Radiol 28(10):1401-1407, 2021. e-Pub 2021. PMID: 32709584.
21. Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Zarifa A, Shah J, Milton DR, Bean S, McQuinn L, Gong J, Colen R, Carter BW, Subbiah V, Ogbonna DC, Pant S, Meric-Bernstam F, Naing A. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs 39(5):1359-1365, 2021. e-Pub 2021. PMID: 33909232.
22. Munden RF, Black WC, Hartman TE, MacMahon H, Ko JP, Dyer DS, Naidich D, Rossi SE, McAdams HP, Goodman EM, Brown K, Kent M, Carter BW, Chiles C, Leung AN, Boiselle PM, Kazerooni EA, Berland LL, Pandharipande PV. Managing incidental findings on thoracic CT, lung findings: a white paper of the ACR incidental findings committee. J Am Coll Radiol 18(9):1267-1279, 2021. e-Pub 2021. PMID: 34246574.
23. Elamin YY, Robichaux JP, Carter BW, Altan M, Gibbons DL, Fossella F, Lam VK, Negrao MV, Le X, Mott F, Lei F, Blumenschein G, Tsao AS, Heymach JV. Poziotinib for Patients with HER2 Exon 20 mutant Non-Small Cell Lung Cancer: Results from a Phase II Trial. J Clin Oncology JC0201113, 2021. e-Pub 2021.
24. Thein KZ, Karp DD, Tsimberdou A, Gong J, Sulovic S, Shah J, Milton DR, Hong DS, Janku F, McQuinn L, Stephen BA, Colen R, Carter BW, Yap TA, Sa P, Fu S, Meric-Bernstam F, Naing A. Selinexor in combination with carboplatin and paclitaxel in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs, 2021. e-Pub 2021.
25. Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
26. Begley CG, Ashton M, Baell J, Bettess M, Brown MP, Carter BW, Charman WN, Davis C, Fisher S, Frazer I, Gautam A, Jennings MP, Kearney P, Keeffe E, Kelly D, Lopez AF, McGuckin M, Parker MW, Rayner C, Roberts B, Rush JS, Sullivan M. Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers. Sci Transl Med 13(612):eabd5524, 2021. e-Pub 2021. PMID: 34550729.
27. Tran HT, Lam VK, Elamin YY, Hong L, Colen R, Elshafeey NA, Hassan ISA, Altan M, Blumenschein GR, Rinsurongkawong W, Rivera MJ, Vasquez ME, Carter BW, Byers LE, Tsao AS, Gibbons DL, Fossella F, Glisson BS, Zhang J, Heymach JV. Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling. JCO Precis Oncol 5, 2021. e-Pub 2021. PMID: 34377884.
28. Thoracic Imaging EPO, Ackman JB, Chung JH, Walker CM, Bang TJ, Carter BW, Hobbs SB, Kandathil A, Lanuti M, Madan R, Moore WH, Shah SD, Verde F, Kanne JP. ACR Appropriateness Criteria® Imaging of Mediastinal Masses. J Am Coll Radiol 18(5S):S37-S51, 2021. e-Pub 2021. PMID: 33958117.
29. Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG, Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J. Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 12(1):2888, 2021. e-Pub 2021. PMID: 33980839.
30. Carter BW. Preface: Modern Imaging of the Mediastinum. Radiol Clin North Am 59(2):xiii, 2021. e-Pub 2021. PMID: 33551089.
31. Cascone T, William WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med 27(3):504-514, 2021. e-Pub 2021. PMID: 33603241.
32. Lee GM, Stowell J, Pope KL, Carter BW, Walker C. Lymphatic Pathways of the Thorax: Predictable Patterns of Spread. AJR AM J Roentgenol 216(3):649-658, 2021. e-Pub 2021. PMID: 33377793.
33. Pelster MS, Gruschkus SK, Bassett R, Gombos DS, Shephard M, Posada L, Glover MS, Simien R, Diab A, Hwu P, Carter BW, Patel SP. Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results from a Single-Arm Phase II Study. J Clin Oncol 39(6):599-607, 2021. e-Pub 2021. PMID: 33125309.
34. Hu X, Estecio M, Chen R, Reuben A, Wang L, Fujimoto J, Carrot-Zhang J, Ying L, Fukuoka J, Chow CW, McGranahan N, Pham H, Godoy M, Carter BW, Behrens C, Zhang J, Antonoff M, Sepesi B, Vaporciyan A, Heymach J, Wistuba I, Pass H, Lu Y, Kadara H, Scheet P, Lee JJ, Futreal A, Su D, Issa JP, Zhang J. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun 12(1):687, 2021. e-Pub 2021. PMID: 33514726.
35. Alessi JV, Ricciuti B, Jiménez-Aguilar E, Hong F, Wei Z, Nishino M, Plodkowski AJ, Sawan P, Luo J, Rizvi H, Carter BW, Heymach JV, Altan M, Hellmann M, Awad M. Outcomes to first-line pembrolizumab in patients with PD-L1-high (=50%) non-small cell lung cancer and a poor performance status. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 32753547.
36. Hasanov M, Rioth MJ, Kendra K, Hernandez-Aya L, Joseph RW, Williamson S, Chandra S, Shirai K, Turner CD, Lewis K, Crowley E, Moscow J, Carter BW, Patel S. A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma. Cancers (Basel) 12(8), 2020. e-Pub 2020. PMID: 32823698.
37. Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone T. 18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother 69(8):1519-1534, 2020. e-Pub 2020. PMID: 32300858.
38. Thoracic Imaging EPO, Cox CW, Chung JH, Ackman JB, Berry MF, Carter BW, de Groot PM, Hobbs SB, Johnson GB, Maldonado F, McComb BL, Tong BC, Walker CM, Kanne JP. ACR Appropriateness Criteria® Occupational Lung Diseases. J Am Coll Radiol 17(5S):S188-S197, 2020. e-Pub 2020. PMID: 32370962.
39. Vascular Imaging EPO, Imaging T, Imaging AN, Zurkiya O, Ganguli S, Kalva SP, Chung JH, Shah LM, Majdalany BS, Bykowski J, Carter BW, Chandra A, Collins JD, Gunn AJ, Kendi AT, Khaja MS, Liebeskind DS, Maldonado F, Obara P, Sutphin PD, Tong BC, Vijay K, Corey AS, Kanne JP, Dill KE. ACR Appropriateness Criteria® Thoracic Outlet Syndrome. J Am Coll Radiol 17(5S):S323-S334, 2020. e-Pub 2020. PMID: 32370976.
40. Roden AC, Fang W, Shen Y, Carter BW, White DB, Jenkins SM, Spears GM, Molina JR, Klang E, Segni MD, Ackman JB, Sanchez EZ, Girard N, Shumeri E, Revel MP, Chassagnon G, Rubinowitz A, Dicks D, Detterbeck F, Ko JP, Falkson CB, Sigurdson S, Segreto S, Del Vecchio S, Palmieri G, Ottaviano M, Marino M, Korst R, Marom EM. Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases. J Thorac Oncol 15(4):568-579, 2020. e-Pub 2020. PMID: 31870881.
41. Gainor JF, Rizvi H, Jimenez Aguilar E, Skoulidis F, Yeap BY, Naidoo J, Khosrowjerdi S, Mooradian M, Lydon C, Illei P, Zhang J, Peterson R, Ricciuti B, Nishino M, Zhang J, Roth JA, Grishman J, Anderson D, Little BP, Carter BW, Arbour K, Sauter JL, Mino-Kenudson M, Heymach JV, Digumarthy S, Shaw AT, Awad MM, Hellmann MD. Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression =50. Ann Oncol 31(3):404-411, 2020. e-Pub 2020. PMID: 32067682.
42. Lin SH, Lin Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Simon G, Skoulidis F, Chang JY, Jeter MD, Liao Z, Gomez DR, O'Reilly M, Papadimitrakopoulou V, Thall P, Heymach JV, Tsao AS. Phase II trial of concurrent atezolizumab with chemoradiation in unresectable non-small cell lung cancer. J Thorac Oncol 15(2):248-257, 2020. e-Pub 2020. PMID: 31778797.
43. Qdaisat A, Yeung SJ, Variyam DE, Badugu P, Ghaly F, Rice TW, Halm JK, Carter BW, Sun J, Gonzalez CE, Viets-Upchurch J, Steele JR, Wu CC. Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians Guideline. J Am Coll Radiol 17(1 Pt A):22-30, 2020. e-Pub 2020. PMID: 31376398.
44. Thoracic Imaging EPO, Lee C, Colletti PM, Chung JH, Ackman JB, Berry MF, Carter BW, de Groot PM, Hobbs SB, Johnson GB, Maldonado F, McComb BL, Tong BC, Walker CM, Kanne JP. ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients. J Am Coll Radiol 16(11S):S331-S339, 2019. e-Pub 2019. PMID: 31685101.
45. Aguilar EJ, Ricciuti B, Gainor JF, Kehl KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo S, Khosrowjerdi S, Peterson RM, Digumarthy S, Liu C, Sauter J, Rizvi H, Arbour KC, Carter BW, Heymach JV, Altan M, Hellmann MD, Awad MM. Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression. Ann Oncol 30(10):1653-1659, 2019. e-Pub 2019. PMID: 31435660.
46. Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong DS, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer 7(1):237, 2019. e-Pub 2019. PMID: 31484556.
47. Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG, Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 10(1):2978, 2019. e-Pub 2019. PMID: 31278276.
48. Thoracic Imaging: EPO, de Groot PM, Chung JH, Ackman JB, Berry MF, Carter BW, Colletti PM, Hobbs SB, McComb BL, Movsas B, Tong BC, Walker CM, Yom SS, Kanne JP. ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer. J Am Coll Radiol 16(5S):S184-S195, 2019. e-Pub 2019. PMID: 31054745.
49. Carter BW, Benveniste MF, Marom EM. Diagnostic approach to the anterior/prevascular mediastinum for radiologists. Mediastinum 3:18, 2019. e-Pub 2019. PMID: 35118246.
50. Stowell JT, Betancourt-Cuellar SL, Carter BW, Wu CC, Walker CM. Thoracic Manifestations of Genitourinary Neoplasms and Treatment-related Complications. J Thorac Imaging 34(3):W36-W48, 2019. e-Pub 2019. PMID: 31009398.
51. Benveniste MF, Gomez D, Carter BW, Betancourt Cuellar SL, Shroff GS, Benveniste APA, Odisio EG, Marom EM. Recognizing Radiation Therapy-related Complications in the Chest. Radiographics 39(2):344-366, 2019. e-Pub 2019. PMID: 30844346.
52. Jensen CT, Blair KJ, Wagner-Bartak NA, Vu LN, Carter BW, Sun J, Bathala TK, Gupta S. Comparison of abdominal computed tomographic enhancement and organ lesion depiction between weight-based scanner software contrast dosing and a fixed-dose protocol in a tertiary care oncologic center. J Comput Assist Tomogr 43(1):155-162, 2019. e-Pub 2019. PMID: 30211799.
53. Shroff GS, Truong MT, Carter BW, Benveniste MF, Kanagal-Shamanna R, Rauch G, Viswanathan C, Boddu PC, Daver N, Wu CC. Leukemic involvement in the thorax. Radiographics 39(1):44-61, 2019. e-Pub 2019. PMID: 30620703.
54. Expert Panel on Thoracic Imaging: McComb BL, Ravenel JG, Steiner RM, Chung JH, Ackman JB, Carter BW, Colletti PM, Crabtree TD, de Groot PM, Iannettoni MD, Jokerst C, Maldonado F, Kanne JP. ACR Appropriateness Criteria® Chronic Dyspnea-Noncardiovascular Origin. J Am Coll Radiol 15(11S):S291-S301, 2018. e-Pub 2018. PMID: 30392598.
55. Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH. Multimodal imaging of pathologic response to chemoradiation in esophageal cancer. Int J Radiat Oncol Biol Phys 102(4):996-1001, 2018. e-Pub 2018. PMID: 29685377.
56. Expert Panel on Thoracic Imaging: Jokerst C, Chung JH, Ackman JB, Carter BW, Colletti PM, Crabtree TD, de Groot PM, Iannettoni MD, Maldonado F, McComb BL, Steiner RM, Kanne JP. ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompetent Patients. J Am Coll Radiol 15(11S):S240-S251, 2018. e-Pub 2018. PMID: 30392593.
57. Gupta S, Rajiah P, Middlebrooks EH, Baruah D, Carter BW, Burton KR, Chatterjee AR, Miller MM. Systematic review of the literature: Best practices. Acad Radiol 11(25):1481-1490, 2018. e-Pub 2018. PMID: 30442379.
58. JPrd L, Biko DM, Carter BW, Pavio MA, Huppmann AR, Chung EM. Primary lung tumors in children: Radiologic-pathologic correlation from the radiologic pathology archives. Radiographics 7(38):2151-2172, 2018. e-Pub 2018. PMID: 30422774.
59. Kalaora S, Wolf Y, Feferman T, Barnea E, Greenstein E, Reshef D, Tirosh I, Reuben A, Patkar S, Levy R, Quinkhardt J, Omokoko T, Qutob N, Golani O, Zhang J, Mao X, Song X, Bernatchez C, Haymaker C, Forget MA, Creasy C, Greenberg P, Carter BW, Cooper ZA, Rosenberg SA, Lotem M, Sahin U, Shakhar G, Ruppin E, Wargo JA, Friedman N, Admon A, Samuels Y. Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma. Cancer Discov 8(11):1366-1375, 2018. e-Pub 2018. PMID: 30209080.
60. Chen L, Diao L, Yang Y, Yi X, Rodriguez BL, Li Y, Villalobos PA, Cascone T, Liu X, Tan L, Lorenzi PL, Huang A, Zhao Q, Peng D, Fradette JJ, Peng DH, Ungewiss C, Roybal J, Tong P, Oba J, Skoulidis F, Peng W, Carter BW, Gay CM, Fan Y, Class CA, Zhu J, Rodriguez-Canales J, Kawakami M, Byers LA, Woodman SE, Papadimitrakopoulou VA, Dmitrovsky E, Wang J, Ullrich SE, Wistuba II, Heymach JV, Qin FX, Gibbons DL. CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade. Cancer Discov 8(9):1156-1175, 2018. e-Pub 2018. PMID: 30012853.
61. Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SH. Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging 45(10):1742-1751, 2018. e-Pub 2018. PMID: 29663014.
62. Munden RF, Carter BW, Chiles C, MacMahon H, Black WC, Ko JP, McAdams HP, Rossi SE, Leung AN, Boiselle PM, Kent MS, Brown K, Dyer DS, Hartman TE, Goodman EM, Naidich DP, Kazerooni EA, Berland LL, Pandharipande PV. Managing incidental findings on thoracic CT: mediastinal and cardiovascular findings. A white aper of the ACR incidental findings committee. J Am Coll Radiol 15(8):1087-1096, 2018. e-Pub 2018. PMID: 29941240.
63. Carter BW, Bhosale PR, Yang WT. Immunotherapy and the role of imaging. Cancer 124(14):2906-2922, 2018. e-Pub 2018. PMID: 29671876.
64. Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV. STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov 8(7):822-835, 2018. e-Pub 2018. PMID: 29773717.
65. Goense L, van Rossum PSN, Xi M, Maru DM, |BCarter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SH. Preoperative nomogram to risk stratify patients for the benefit of trimodality therapy in esophageal adenocarcinoma. Ann Surg Oncol 25(6):1598-1607, 2018. e-Pub 2018. PMID: 29569125.
66. Robichaux JP, Elamin YY, Tan Z, Carter BW, Zhang S, Liu S, Li S, Chen T, Poteete A, Estrada-Bernal A, Le AT, Truini A, Nilsson MB, Sun H, Roarty E, Goldberg SB, Brahmer JR, Altan M, Lu C, Papadimitrakopoulou V, Politi K, Doebele RC, Wong KK, Heymach JV. Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nat Med 24(5):638-646, 2018. e-Pub 2018. PMID: 29686424.
67. Lichtenberger JP, Kim AM, Fisher D, Tatum PS, Neubauer B, Peterson PG, Carter BW. Imaging of combat-related thoracic trauma - blunt trauma and blast lung injury. Mil Med 1(183):3-4, 2018. e-Pub 2018. PMID: 29514343.
68. Carter BW, Lichtenberger JP III, Benveniste MF, de Groot PM, Wu CC, Erasmus JJ, Truong MT. Revisions to the TNM staging of lung cancer: rationale, significance, and clinical application. Radiographics 2(38):374-391, 2018. e-Pub 2018. PMID: 29528831.
69. Carter BW, Lichtenberger JP, Wu CC, Munden RF. Screening for lung cancer: lexicon for communicating with health care providers. AJR Am J Roentgenol 210(3):473-479, 2018. e-Pub 2018. PMID: 29261349.
70. Kim AM, Hunter TA, McQuillan BF, Franco DF, Griffith TP, Carter BW, JPrd L. Imaging in congenital and hereditary abnormalities of the interventricular septum: Clinical anatomy and diagnostic clues. J Thorac Imaging 3(33):147-155, 2018. e-Pub 2018. PMID: 29489583.
71. Madan R, Laur O, Crudup B, Peavy L, Carter BW. Imaging of iatrogenic esophageal injuries using optimized CT esophageal leak protocol: pearls and pitfalls. Br J Radiol 91(1083):20170629, 2018. e-Pub 2018. PMID: 29166132.
72. Betancourt-Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EM. 18FDG-PET/CT is useful in the follow-up of surgically treated patients with esophageal adenocarcinoma. Br J Radiol 91(1082):20170341, 2018. e-Pub 2018. PMID: 29125331.
73. Tsao AS, Lin H, Carter BW, Lee JJ, Rice D, Vaporcyan A, Swisher S, Mehran R, Heymach J, Nilsson M, Fan Y, Nunez M, Diao L, Wang J, Fujimoto J, Wistuba II, Hong WK. Biomarker-integrated neoadjuvant dasatinib trial in resectable malignant pleural mesothelioma. J Thorac Oncol 2(13):246-257. e-Pub 2017. PMID: 29313814.
74. Carter BW, Steele JR, Sun J, Wu CC. Analysis of the completeness and clarity of free-form radiology dictations for the reporting of pulmonary embolism. J Am Coll Radiol 14(12):1556-1559, 2017. e-Pub 2017. PMID: 28427907.
75. Carter BW, Halpenny DF, Ginsberg MS, Papadimitrakopoulou VA, de Groot PM. Immunotherapy in non-small cell lung cancer treatment: current status and the role of imaging. J Thorac Imaging 32(5):300-312, 2017. e-Pub 2017. PMID: 28786858.
76. Benveniste MF, Gomez D, Viswanathan C, Shroff GS, Betancourt Cuellar SL, Carter BW, Marom EM. Lung cancer: posttreatment imaging: radiation therapy and imaging findings. J Thorac Imaging 32(5):288-299, 2017. e-Pub 2017. PMID: 28832415.
77. de Groot PM, Shroff GS, Carter BW, Godoy MCB, Plodkowski AJ, P Ko J, Munden RF. Lung cancer: postoperative imaging and complications. J Thorac Imaging 32(5):276-287, 2017. e-Pub 2017. PMID: 28832414.
78. de Groot PM, Shroff GS, Carter BW, Godoy MCB, Plodkowski A, Ko J, Munden RF. Lung Cancer: Postoperative Imaging and Complications. J Thorac Imaging 32(5):276-287, 2017. e-Pub 2017. PMID: 28832414.
79. Carter BW, Erasmus JJ, Truong MT, Shepard JO, Hofstetter W, Clarke R, Munden RF, Steele JR. Quality and value of subspecialty reinterpretation of thoracic CT scans of patients referred to a tertiary cancer center. J Am Coll Radiol 14(8):1109-1118, 2017. e-Pub 2017. PMID: 28434844.
80. Godoy MCB, Pereira HAC, Carter BW, Wu CC, Erasmus JJ. Incidental findings in lung cancer screening: which ones are relevant?. Semin Roentgenol 52(3):156-160, 2017. e-Pub 2017. PMID: 28734397.
81. de Groot PM, Shroff GS, Carter BW, Godoy MCB, Plodkowski A, Ko J, Munden RF. Lung cancer: posttherapy imaging and complications. J Thoracic Imaging, 2017. e-Pub 2017. PMID: 28746091.
82. Carter BW, Benveniste MF, Madan R, Godoy MC, de Groot PM, Truong MT, Rosado-de-Christenson ML, Marom EM. IASLC/ITMIG staging system and lymph node map for thymic epithelial neoplasms. Radiographics 37(3):758-776, 2017. e-Pub 2017. PMID: 28493800.
83. Reuben A, Spencer CN, Prieto PA, Gopalakrishnan V, Reddy SM, Miller JP, Mao X, De Macedo MP, Chen J, Song X, Jiang H, Chen PL, Beird HC, Garber HR, Roh W, Wani K, Chen E, Haymaker C, Forget MA, Little LD, Gumbs C, Thornton RL, Hudgens CW, Chen WS, Austin-Breneman J, Sloane RS, Nezi L, Cogdill AP, Bernatchez C, Roszik J, Hwu P, Woodman SE, Chin L, Tawbi H, Davies MA, Gershenwald JE, Amaria RN, Glitza IC, Diab A, Patel SP, Hu J, Lee JE, Grimm EA, Tetzlaff MT, Lazar AJ, Wistuba II, Clise-Dwyer K, Carter BW, Zhang J, Futreal PA, Sharma P, Allison JP, Cooper ZA, Wargo JA. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom Med 2(1):10, 2017. e-Pub 2017. PMID: 28819565.
84. Betancourt Cuellar SL, Sabloff B, Carter BW, Benveniste MF, Correa AM, Maru DM, Ajani JA, Erasmus JJ, Hofstetter WL. Early clinical esophageal adenocarcinoma (cT1): utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?. Eur J Radiol 88:56-60, 2017. e-Pub 2017. PMID: 28189209.
85. Carter BW, Benveniste MF, Madan R, Godoy MC, de Groot PM, Truong MT, Rosado-de-Christenson ML, Marom EM. ITMIG classification of mediastinal compartments and multidisciplinary approach to mediastinal masses. Radiographics 37(2):160095, 2017. e-Pub 2017. PMID: 28129068.
86. van Rossum PS, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, Carter BW, Court LE, Lin SH. The value of (18)F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. Eur J Nucl Med Mol Imaging 44(1):71-80, 2017. e-Pub 2017. PMID: 27511188.
87. Lichtenberger JP, Reynolds DA, Keung J, Keung E, Carter BW. Metastasis to the heart: a radiologic approach to diagnosis with pathologic correlation. AJR Am J Roentgenol 207(4):764-772, 2016. e-Pub 2016. PMID: 27490329.
88. Pavlus JD, Carter BW, Tolley MD, Keung ES, Khorashadi L, Lichtenberger JP. Imaging of thoracic neurogenic tumors. AJR Am J Roentgenol 207(3):1-10, 2016. e-Pub 2016. PMID: 27340927.
89. Carter BW, Benveniste MF, Betancourt SL, de Groot PM, Lichtenberger JP, Amini B, Abbott GF. Imaging evaluation of malignant chest wall neoplasms. Radiographics 36(5):150208, 2016. e-Pub 2016. PMID: 27494286.
90. Hobbs SB, Martin JT, Walker CM, Carter BW, Chung JH. Nodular pleural thickening after lobectomy for lung cancer. Insights on imaging of the pleura. Ann Am Thorac Soc 13(8):1424-1425, 2016. e-Pub 2016. PMID: 27509157.
91. Carter BW, Walker CM, Hobbs SB, Chung JH. A subsolid pulmonary lesion. Diagnostic considerations and management options. Ann Am Thorac Soc 13(7):1180-2, 2016. e-Pub 2016. PMID: 27388406.
92. Carter BW, Godoy MC, Wu CC, Erasmus JJ, Truong MT. Current controversies in lung cancer staging. J Thorac Imaging 31(4):201-14, 2016. e-Pub 2016. PMID: 27306388.
93. Cho J, Ibbott GS, Kerr MD, Amos RA, Stingo FC, Marom EM, Truong MT, Palacio DM, Betancourt SL, Erasmus JJ, de Groot PM, Carter BW, Gladish GW, Sabloff BS, Benveniste MF, Godoy MC, Patil S, Sorensen J, Mawlawi OR. Characterizing proton-activated materials to develop PET-mediated proton range verification markers. Phys Med Biol 61(11):N291-310, 2016. e-Pub 2016. PMID: 27203621.
94. Hobbs SB, Walker CM, Carter BW, Chung JH. Progressive dyspnea in a patient with asthma. Insights on computed tomographic imaging of the airway. Ann Am Thorac Soc 13(2):292-4, 2016. e-Pub 2016. PMID: 26848604.
95. Walker CM, Hobbs SB, Carter BW, Chung JH. Dyspnea, cough, and abnormal thoracic imaging after lung transplantation. Ann Am Thorac Soc 13(1):134-6, 2016. e-Pub 2016. PMID: 26730869.
96. Carter BW, Betancourt SL, Viswanathan C, Mawlawi O, Marom EM, Truong MT. Potential pitfalls in interpretation of positron emission tomography/computed tomography findings in the thorax. Semin Roentgenol 50(3):210-6, 2015. e-Pub 2015. PMID: 26002241.
97. Carter BW, Erasmus JJ. Acute thoracic findings in oncologic patients. J Thorac Imaging 30(4):233-46, 2015. e-Pub 2015. PMID: 25803363.
98. Elmariah S, Mutrie CJ, Mehrotra P, Carter BW, Drachman DE, Walker JD. Percutaneous extraction of pacing leads from the left coronary artery and left ventricle. EuroIntervention 11(3):e1-2, 2015. e-Pub 2015. PMID: 25022227.
99. Godoy MC, Marom EM, Carter BW, Sorensen J, Truong MT, Abbott GF. Computed tomography imaging of lung infection in the oncologic setting: typical features and potential pitfalls. Semin Roentgenol 50(3):192-6, 2015. e-Pub 2015. PMID: 26002239.
100. Yang L, Son JB, Ma J, Cheng S, Hazle J, Carter BW, Lin S. MO-F-CAMPUS-I-05: quantitative ADC measurement of esophageal cancer before and after chemoradiation. Med Phys 42(6):3579, 2015. e-Pub 2015. PMID: 26128770.
101. Nickell LT, Lichtenberger JP, Khorashadi L, Abbott GF, Carter BW. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics 34(6):1692-706, 2014. e-Pub 2014. PMID: 25310424.
102. Carter BW, Glisson BS, Truong MT, Erasmus JJ. Small cell lung carcinoma: staging, imaging, and treatment considerations. Radiographics 34(6):1707-21, 2014. e-Pub 2014. PMID: 25310425.
103. Carter BW, Tomiyama N, Bhora FY, Rosado de Christenson ML, Nakajima J, Boiselle PM, Detterbeck FC, Marom EM. A modern definition of mediastinal compartments. J Thorac Oncol 9(9 Suppl 2):S97-S101, 2014. e-Pub 2014. PMID: 25396318.
104. Carter BW, Okumura M, Detterbeck FC, Marom EM. Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol 9(9 Suppl 2):S110-8, 2014. e-Pub 2014. PMID: 25396307.
105. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-1206, 2014. e-Pub 2014. PMID: 25157774.
106. Carter BW, Lichtenberger JP, Wu CC. Acquired abnormalities of the pulmonary arteries. AJR Am J Roentgenol 202(5):W415-21, 2014. e-Pub 2014. PMID: 24758676.
107. Carter BW, Lichtenberger JP, Wu CC. Congenital abnormalities of the pulmonary arteries in adults. AJR Am J Roentgenol 202(4):W308-13, 2014. e-Pub 2014. PMID: 24660728.
108. Steel CJ, Carter BW, Thoreson AA, Jesinger RA, Lichtenberger JP III. Superior vena cava syndrome: a multimodality approach to diagnosis and treatment. Contemporary Diagnostic Radiology 36(18):1-5, 2013. e-Pub 2013.
109. Levine HR, Tingle E, Carter BW, Dockery D. Synovial metastasis from lung cancer. Proc (Bayl Univ Med Cent) 26(1):25-7, 2013. e-Pub 2013. PMID: 23382605.
110. Yactor AR, Michell MN, Koch MS, Leete TG, Shah ZA, Carter BW. Percutaneous tattoo pigment simulating calcific deposits in axillary lymph nodes. Proc (Bayl Univ Med Cent) 26(1):28-9, 2013. e-Pub 2013. PMID: 23382606.
111. Wang Y, Carter BW, Muse V, Digumarthy S, Shepard JA, Sharma A. Potential pitfall in the assessment of lung cancer with FDG-PET/CT: talc pleurodesis causes intrathoracic nodal FDG avidity. Lung Cancer Int 2013:683582, 2013. e-Pub 2013. PMID: 26316941.
112. Zarghouni M, Seale TM, Ogden E, Savage CM, Carter BW. Benign endobronchial granular cell tumor resulting in right middle lobe collapse. Proc (Bayl Univ Med Cent) 25(4):365-6, 2012. e-Pub 2012. PMID: 23077389.
113. Fathi AT, Chen YB, Carter BW, Ryan RJ. Case records of the Massachusetts General Hospital. Case 24-2012. A 38-year-old man with abdominal pain and altered mental status. N Engl J Med 367(6):552-63, 2012. e-Pub 2012. PMID: 22873536.
114. Taylor WB, Lloyd MD, Mendeloff EN, Laird WP, Dockery WD, Carter BW. Anomalous origin of the right coronary artery from the pulmonary trunk demonstrated by electrocardiographically gated computed tomography coronary angiography. Proc (Bayl Univ Med Cent) 25(3):289-90, 2012. e-Pub 2012. PMID: 22754138.
115. Fitzpatrick MC, Carter BW. Pulmonary mucormycosis complicating cutaneous blastic plasmacytoid dendritic cell neoplasm. Proc (Bayl Univ Med Cent) 25(3):287-8, 2012. e-Pub 2012. PMID: 22754137.
116. Carter BW. Hermansky-Pudlak syndrome complicated by pulmonary fibrosis. Proc (Bayl Univ Med Cent) 25(1):76-7, 2012. e-Pub 2012. PMID: 22275791.
117. Carter BW, Khorashadi L, Lichtenberger JP. A tracheal lesion simulating an aneurysmal bone cyst. Proc (Bayl Univ Med Cent) 24(4):354-5, 2011. e-Pub 2011. PMID: 22046075.
118. Carter BW, Schucany WG. Brown adipose tissue in a newborn. Proc (Bayl Univ Med Cent) 21(3):328-30, 2008. e-Pub 2008. PMID: 18628932.
119. McGuire SL, Roe DL, Carter BW, Carter RL, Grace SP, Hays PL, Lang GA, Mamaril JL, McElvaine AT, Payne AM, Schrader MD, Wahrle SE, Young CD. Extragenic suppressors of the nimX2(cdc2) mutation of Aspergillus nidulans affect nuclear division, septation and conidiation. Genetics 156(4):1573-84, 2000. e-Pub 2000. PMID: 11102358.
120. Carter BW, Chung JH, Ackman JB, Berry MF, Colletti PM, de Groot PM, Hobbs SB, McComb BL, Moysas B, Tong BC, Walker CM, Yom SS, Kanne JP. ACR Appropriateness Criteria: Sepsis. J Am Coll Radiol.
121. Stowell JT, Walker CM, Chung JH, Bang TJ, Carter BW, Christensen JD, Donnelly EF, Hanna TN, Hobbs SB, Johnson BD, Kandathil A, Lo BM, Madan R, Majercik S, Moore WH, Kanne JP. ACR Appropriateness Criteria: Nontraumatic Chest Wall Pain. J Am Coll Radiol.
122. Godoy MC, Sorensen J, Carter BW, Truong MT, Patel S. Coronary artery imaging pitfalls. Semin Roentgenol.
123. Benveniste MF, Betancourt Cuellar SL Carter BW, Strange CD, Marom EM. Thymic Epithelial Neoplasms: TNM Staging. Rad Clin North America.

Invited Articles

1. Strange CD Marom EM, Ahuja J, Shroff GS, Gladish GW, Carter BW, Truong MT. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma. Adv Anat Pathol 30(4):280-291, 2023. e-Pub 2023.
2. Carter BW, Altan M, Shroff GS, Truong MT, Vlahos I. Post chemotherapy and targeted therapy imaging of the chest in lung cancer. Clin Radiol 77(1):e1-e10, 2022. e-Pub 2022.
3. Shroff GS, Strange CD, Altan M, Carter BW, Ahuja J, Godoy MCB, Truong MT, Vlahos I. Imaging of immunotherapy in lung cancer. Clin Radiol 5:S0009-9260(21):00258-0, 2021. e-Pub 2021.
4. Carter BW. Thymic Malignancy Interest Group Model of Mediastinal Compartments. Radiol Clin North Am 59(2):149-153, 2021. e-Pub 2021.
5. Benveniste MFK, Betancourt Cuellar SL, Carter BW Strange CD Marom EM. Thymic Epithelial Neoplasms: Tumor-Node-Metastasis Staging. Radio Clin Am 59(2):183-192, 2021. e-Pub 2021.
6. Carter BW, Godoy MCB. DECT of pulmonary nodules and masses. American Roentgen Ray Society Categorical Course Syllabus, 2021. e-Pub 2021.
7. Carter BW. Update on lung cancer staging: the must-knows of TNM-8. American Roentgen Ray Society Categorical Course Syllabus, 2019. e-Pub 2019.
8. Carter BW, Erasmus JJ. Diagnosis and staging of lung cancer. Diseases of the Chest, Breast, Heart, and Vessels Course Syllabus, 2019. e-Pub 2019.
9. Shroff GS, Viswanathan C, Carter BW, Benveniste MF, Truong MT, Sabloff BS. Staging lung cancer: metastasis. Radiol Clin North Am 56(3):411-418, 2018. e-Pub 2018. PMID: 29622076.
10. Tsai EB, Chiles C, Carter BW, Godoy MCB, Shroff GS, Munden RF, Truong MT, Wu CC. Incidental Findings on Lung Cancer Screening: Significance and Management. Semin Ultrasound CT MR 39(3):273-281, 2018. e-Pub 2018. PMID: 29807637.
11. Benveniste MF, Betancourt Cuellar SL, Gomez D, Shroff GS, Carter BW, Benveniste APA, Marom EM. Imaging of Radiation Treatment of Lung Cancer. Semin Ultrasound CT MR 39(3):297-307, 2018. e-Pub 2018. PMID: 29807640.
12. Shroff GS, Benveniste MF, de Groot PM, Carter BW, Wu CC, Viswanathan C, Truong MT. Imaging on Lung Cancer and Treatment with Targeted Therapy. Semin Ultrasound CT MR 39(3):308-313, 2018. e-Pub 2018. PMID: 29807641.
13. Carter BW. Immunotherapy in lung cancer and the role of imaging. Semin Ultrasound CT MR:314-321, 2018. e-Pub 2018. PMID: 29807642.
14. Shroff GS, Sabloff BS, Truong MT, Carter BW, Viswanathan C. PET/CT Interpretative Pitfalls in Thoracic Malignancies. Semin Ultrasound CT MR 39(3):282-288, 2018. e-Pub 2018. PMID: 29807638.
15. Benveniste MF, Welsh J, Viswanathan C, Shroff GS, Betancourt Cuellar SL, Carter BW, Marom EM. Lung cancer: posttreatment imaging: radiation therapy and imaging findings. Radiol Clin North Am, 2018. e-Pub 2018. PMID: 29622079.
16. Shroff GS, de Groot PM, Papadimitrakopoulou VA, Truong MT, Carter BW. Targeted Therapy and immunotherapy in the treatment of non-small Cell lung cancer. Radiol Clin North Am, 2018. e-Pub 2018. PMID: 29622080.
17. Hossain R, Wu CC, de Groot PM, Carter BW, Gilman MD, Abbott GF. Missed Lung Cancer. Radiol Clin North Am(56(3)):365-375, 2018. e-Pub 2018. PMID: 29622072.
18. El-Sherief AH, Lau CT, Carter BW, Wu CC. Staging lung cancer: regional lymph node classification. Radiol Clin North Am(56(3)):399-409, 2018. e-Pub 2018. PMID: 29622075.
19. Bueno J, JPrd L, Rauch G, Carter BW. MR Imaging of Primary Chest Wall Neoplasms. Top Magn Reson Imaging, 2018. e-Pub 2018. PMID: 29613963.
20. JPrd L, Franco DF, Kim JS, Carter BW. MR Imaging of Thoracic Aortic Disease. Top Magn Reson Imaging, 2018. e-Pub 2018. PMID: 29613964.
21. Carter BW, Lichtenberger JP, Benveniste MF. MR Imaging of Thymic Epithelial Neoplasms. Top Magn Reson Imaging 27(2):65-71, 2018. e-Pub 2018. PMID: 29613961.
22. JPrd L, Dulberger AR, Gonzales PE, Bueno J, Carter BW. MR Imaging of cardiac masses. Top Magn Reson Imaging, 2018. e-Pub 2018. PMID: 29613965.
23. Carter BW, Betancourt SL, Shroff GS, Lichtenberger JP. MR Imaging of Pleural Neoplasms. Top Magn Reson Imaging 27(2):73-82, 2018. e-Pub 2018. PMID: 29613962.
24. Carter BW, Betancourt SL, Benveniste MF. MR imaging of mediastinal masses. Top Magn Reson Imaging 26(4):153-165, 2017. e-Pub 2017. PMID: 28777164.
25. Betancourt Cuellar SL, Palacio DP, Benveniste MF, Carter BW, Hofstetter WL, Marom EM. Positron emission tomography / computed tomography in esophageal carcinoma: applications and limitations. Semin Ultrasound CT MR, 2017. e-Pub 2017.
26. Shroff GS, Benveniste MF, Carter BW, de Groot PM, Wu CC, Viswanathan C, Sabloff BS, Truong MT. Imaging of metastases in the chest: mechanisms of spread and potential pitfalls. Semin Ultrasound CT MR, 2017. e-Pub 2017.
27. Godoy MCB, Pereira HAC, Carter BW, Wu CC, Erasmus JJ. Incidental finding in lung cancer screening: which ones are relevant?. Semin Rooentgenol 52(3):156-160, 2017. e-Pub 2017. PMID: 28734397.
28. Carter BW, Lichtenberger JP, Shroff GS, Truong MT, Wu CC. Role of fluorodeoxyglucose positron emission tomography-computed tomography in the evaluation of suspicious pulmonary nodules. Semin Roentgenol 52(3):166-172, 2017. e-Pub 2017. PMID: 28734399.
29. Carter BW, Lichtenberger JP, Shroff GS, Wu CC. Lung computed tomography screening reporting and data system version 1.0. Semin Roentgenol 52(3):137-142, 2017. e-Pub 2017. PMID: 28734395.
30. Price M, Gilman MD, Carter BW, Sabloff BS, Truong MT, Wu CC. Imaging of eosinophilic lung diseases. Radiol Clin North Am 54(6):1151-1164, 2016. e-Pub 2016. PMID: 27719981.
31. Walker CM, Hobbs SB, Carter BW, Chung JH. Progressive dyspnea with cough. Ann Am Thorac Soc 13(9):1654-6, 2016. e-Pub 2016. PMID: 27627477.
32. Shroff GS, Ocazionez D, Vargas D, Carter BW, Wu CC, Nachiappan AC, Gupta P, Restrepo CS. Pathology of the trachea and central bronchi. Semin Ultrasound CT MR 37(3):177-89, 2016. e-Pub 2016. PMID: 27261343.
33. Benveniste MF, Gomez D, Carter BW, Betancourt Cuellar SL, De Groot PM, Marom EM. Radiation effects in the mediastinum and surroundings: imaging findings and complications. Semin Ultrasound CT MR 37(3):268-80, 2016. e-Pub 2016. PMID: 27261350.
34. Wu CC, Carter BW, Erasmus JJ. Lung-RADS. American Roentgen Ray Society Categorical Course Syllabus, 2016. e-Pub 2016.
35. Carter BW, Wu CC, Godoy MCB, Erasmus JJ. Lung cancer staging: what the surgeon needs to know. American Roentgen Ray Society Categorical Course Syllabus, 2016. e-Pub 2016.
36. Viswanathan C, Carter BW, Shroff GS, Godoy MC, Marom EM, Truong MT. Pitfalls in oncologic imaging: complications of chemotherapy and radiotherapy in the chest. Semin Roentgenol 50(3):183-91, 2015. e-Pub 2015. PMID: 26002238.
37. de Groot PM, Carter BW, Abbott GF, Wu CC. Pitfalls in chest radiographic interpretation: blind spots. Semin Roentgenol 50(3):197-209, 2015. e-Pub 2015. PMID: 26002240.
38. Godoy MC, Marom EM, Carter BW. CT imaging of lung infection in the oncologic setting: typical features and potential pitfalls. Semin Roentgenol 3(50):192-6, 2015. e-Pub 2015.
39. Godoy MC, Marom EM, Carter BW, Sorensen J, Truong MT, Abbott GF. Computed tomography imaging of lunch infection in the oncologic setting: typical features and potential pitfalls. Semin Roentgenol 50(3):192-6, 2015. e-Pub 2015. PMID: 26002239.
40. Carter BW, Betancourt SL, Viswanathan C, Mawlawi O, Marom EM, Truong MT. Potential pitfalls in interpretation of positron emission tomography/computed findings in the thorax. Semin Roentgenol 50(3):210-216, 2015. e-Pub 2015. PMID: 26002241.
41. Lichtenberger JP, Carter BW, Abbott GF. Pitfalls in imaging of the chest wall. Semin Roentgenol 50(3):251-7, 2015. e-Pub 2015. PMID: 26002247.
42. Godoy MC, Truong MT, Carter BW, Viswanathan C, de Groot P, Ko JP. Pitfalls in pulmonary nodule characterization. Semin Roentgenol 50(3):164-74, 2015. e-Pub 2015. PMID: 26002236.
43. Carter BW, de Groot PM, Godoy MC, Marom EM, Wu CC. Imaging of the mediastinum: vascular lesions as a potential pitfall. Semin Roentgenol 50(3):241-50, 2015. e-Pub 2015. PMID: 26002246.
44. Godoy MC, Marom EM, Carter BW, Sorensen J, Truong MT, Abbott GF. Computed tomography imaging of lung infection in the oncologic setting: typical features and potential pitfalls. Semin Roentgenol 50(3):192-6, 2015. e-Pub 2015. PMID: 26002239.
45. Carter BW, de Groot PM, Marom EM, Truong MT, Viswanathan C. Pitfalls in PET/CT in the thorax. Semin Roentgenol 3(50):210-6, 2015. e-Pub 2015.
46. Betancourt-Cuellar SL, Carter BW, Palacio D, Erasmus JJ. Pitfalls and limitations in non-small cell lung cancer staging. Semin Roentgenol 50(3):175-82, 2015. e-Pub 2015. PMID: 26002237.
47. de Groot PM, Carter BW, Betancourt Cuellar SL, Erasmus JJ. Staging of lung cancer. Clin Chest Med 36(2):179-196, 2015. e-Pub 2015. PMID: 26024599.
48. Carter BW, Gladish GW. MR imaging of chest wall tumors. Magn Reson Imaging Clin N Am 23(2):197-215, 2015. e-Pub 2015. PMID: 25952515.
49. Carter BW, Benveniste MF, Truong MT, Marom EM. State of the art: MR imaging of thymoma. Magn Reson Imaging Clin N Am 23(2):165-177, 2015. e-Pub 2015. PMID: 25952513.
50. de Groot PM, Carter BW, Godoy MC, Munden RF. Lung cancer screening-why do it? Tobacco, the history of screening, and future challenges. Semin Roentgenol 50(2):72-81, 2015. e-Pub 2015. PMID: 25770337.
51. Carter BW, de Groot PM, Godoy MC, Munden RF. Lung cancer screening: how to do it?. Semin Roentgenol 50(2):82-7, 2015. e-Pub 2015. PMID: 25770338.
52. Truong MT, Viswanathan C, Carter BW, Mawlawi O, Marom EM. PET/CT in the thorax: pitfalls. Radiol Clin North Am 52(1):17-25, 2014. e-Pub 2014. PMID: 24267708.
53. Truong MT, Viswanathan C, Godoy MB, Carter BW, Marom EM. Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations. Semin Roentgenol 48(4):323-34, 2013. e-Pub 2013. PMID: 24034264.
54. Carter BW, Lichtenberger JP III. Imaging of the posterior/paravertebral mediastinal compartment. Radiol Clin North Am. 2021.
55. Lichtenberger JP III, Carter BW, Pavio MA, Biko DM. Cardiac neoplasms: radiologic-pathologic correlation. Radiol Clin North Am. 2021.
56. Lichtenberger JP III, Carter BW, Fisher DA, Parker FA, Peterson. Thymic epithelial neoplasms: radiologic-pathologic correlation. Radiol Clin North Am. 2021 59(2):169-182.
57. Lichtenberger JP III, Zeman MN, Dulberger AR, Carter BW, Manning MA. Esophageal neoplasms: radiologic-pathologic correlation. Radiol Clin North Am. 2021.
58. Carter BW. ITMIG definition of mediastinal compartments. Radiol Clin North Am. 2021.

Review Articles

1. Shroff GS, Strange CD, Altan M, Carter BW, Ahuja J, Godoy MCB, Truong MT, Vlahos I. Post-immunotherapy imaging in lung cancer. Clin Radiol 77(1):44-57, 2022. e-Pub 2022. PMID: 34103147.
2. Carter BW, Altan M, Shroff GS, Truong MT, Vlahos I. Post-chemotherapy and targeted therapy imaging of the chest in lung cancer. Clin Radiol 77(1):e1-e10, 2022. e-Pub 2022. PMID: 34538577.
3. Carter BW, Lichtenberger JP. Imaging of the Posterior/Paravertebral Mediastinum. Radiol Clin North Am 59(2):243-249, 2021. e-Pub 2021. PMID: 33551085.
4. Carter BW. International Thymic Malignancy Interest Group Model of Mediastinal Compartments. Radiol Clin North Am 59(2):149-153, 2021. e-Pub 2021. PMID: 33551077.
5. Benveniste MFK, Betancourt Cuellar SL, Carter BW, Strange CD, Marom EM. Thymic Epithelial Neoplasms: Tumor-Node-Metastasis Staging. Radiol Clin North Am 59(2):183-192, 2021. e-Pub 2021. PMID: 33551080.
6. Virarkar M, Viswanathan C, Iyer R, de Castro Faria S, Morani A, Carter BW, Ganeshan D, Elsherif S, Bhosale PR. The Role of Positron Emission Tomography/Magnetic Resonance Imaging in Gynecological Malignancies. J Comput Assist Tomogr 43(6):825-834, 2019. e-Pub 2019. PMID: 31453978.
7. Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter BW, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA, Consortium members INM, Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Lancet Oncol 20(7):e378-e389, 2019. e-Pub 2019. PMID: 31267972.
8. Betancourt Cuellar SL, Palacio D, Benveniste MF, Carter BW, Gladish G. Pitfalls and misinterpretations of cardiac findings on PET/CT imaging: A careful look at the heart in oncology patients. Curr Probl Diagn Radiol 48(2):172-183, 2019. e-Pub 2019. PMID: 29549978.
9. Madan R, Ratanaprasatporn L, Carter BW, Ackman JB. Cystic mediastinal masses and the role of MRI. Clin Imaging 50:68-77, 2018. e-Pub 2018. PMID: 29324329.
10. de Groot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res 7(3):220-233, 2018. e-Pub 2018. PMID: 30050761.
11. Lichtenberger JP, Kim AM, Fisher D, Tatum PS, Neubauer B, Peterson PG, Carter BW. Imaging of combat-related thoracic trauma - review of penetrating trauma. Mil Med 183(3-4):e81-e88, 2018. e-Pub 2018. PMID: 29514336.
12. Shroff GS, Carter BW, Viswanathan C, Benveniste MF, Wu CC, Marom EM, Mawlawi OR, Truong MT. Challenges in interpretation of staging PET/CT in thoracic malignancies. Curr Probl Diagn Radiol 46(4):330-341, 2017. e-Pub 2017. PMID: 28159371.
13. Khorashadi L, Wu CC, Betancourt SL, Carter BW. Idiopathic pulmonary haemosiderosis: spectrum of thoracic imaging findings in the adult patient. Clin Radiol, 2015. e-Pub 2015. PMID: 25515792.
14. Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol 9(9 Suppl 2):S102-9, 2014. e-Pub 2014. PMID: 25396306.
15. Carter BW, Wu CC, Khorashadi L, Godoy MC, de Groot PM, Abbott GF, Lichtenberger JP. Multimodality imaging of cardiothoracic lymphoma. Eur J Radiol 83(8):1470-82, 2014. e-Pub 2014. PMID: 24935137.

Professional Educational Materials

1. Carter BW. Extravasation Algorithm. The University of Texas MD Anderson Cancer Center, 2021.
2. Carter BW. Small Cell Lung Cancer Practice Algorithm. The University of Texas MD Anderson Cancer Center, 2020.
3. Carter BW. Contrast Reaction Management Algorithm. The University of Texas MD Anderson Cancer Center, 2019.
4. Carter BW. Testicular Cancer Practice Algorithm. The University of Texas MD Anderson Cancer Center, 2019.
5. Carter BW. Non-small Cell Lung Cancer Practice Algorithm. The University of Texas MD Anderson Cancer Center, 2019.
6. Takahashi E, Carter BW. Sarcoidosis Mimicking Progressive Massive Fibrosis. ACR Case in Point, 2013.
7. Fitzpatrick M, Carter BW. Bronchopleural Fistula. ACR Case in Point, 2013.
8. Nickell L, Carter BW. Talc Pleurodesis. ACR Case in Point, 2013.
9. Taylor WB, Carter BW. Pleural Metastases. ACR Case in Point, 2013.
10. Swineford S, Carter BW. Secondary Pulmonary Lymphoma. ACR Case in Point, 2012.
11. Patel P, Carter BW. Idiopathic Pulmonary Hemosiderosis. ACR Case in Point, 2012.
12. Barry S, Carter BW. Thymic Hyperplasia. ACR Case in Point, 2012.
13. Islam S, Carter BW. Complicated Silicosis (Progressive Massive Fibrosis). ACR Case in Point, 2012.
14. Lumby C, Carter BW. Tuberous Sclerosis Complex. ACR Case in Point, 2012.
15. Khorashadi L, Carter BW, Martinez F, Venkatesh V, Kalra MK, Abbara S. Bad Connection – Left Circumflex to Coronary Sinus Fistula. Cardiovascular Images e-Newsletter, 2011.
16. Lichtenberger JP, Medina HM, Carter BW, Woo J, Venkatesh V, Abbara S. Fever in a Young Man with Mechanical Valves. Cardiovascular Images e-Newsletter, 2011.
17. Sigakis C, Venkatesh V, Carter BW, Goehler A, Abbara S. Apical hypertrophic cardiomyopathy: calling a spade a spade. Cardiovascular Images e-Newsletter, 2010.

Editorials

1. Carter BW. Machine Learning Algorithms Utilizing Functional Respiratory Imaging May Predict COPD Exacerbations. Acad Radiol 26(9):1200-1201, 2019. PMID: 31229356.
2. Carter BW. MR Imaging of Chest and Chest Wall Disease. Top Magn Reson Imaging 27(2):63-64, 2018. PMID: 29613960.
3. Carter BW, Marom EM. Assessment of the ITMIG statement on the WHO histological classification and of the 8th TNM staging of thymic epithelial tumors, of a series of 188 thymic epithelial tumors. Mediastinum, 2018.
4. Carter BW, Marom EM. Multidisciplinary tumor board decision-making for postoperative radiotherapy in thymic epithelial tumors: Insights from the RYTHMIC prospective cohort. Mediastinum, 2018.
5. Carter BW. Bacterial contamination of CT equipment: use of ATP detection and culture results to target quality improvement. Acad Radiol 24(8):921-922, 2017. PMID: 28549869.
6. Carter BW, Godoy MC, Erasmus JJ. Predicting malignant nodules from screening CTs. J Thorac Oncol 11(12):2045-2047, 2016. PMID: 27866632.
7. Carter BW. The figley fellowship: an introduction to the essential principles of radiology journalism. AJR Am J Roentgenol 207(3):459, 2016. PMID: 27547998.
8. Carter BW. Modern imaging of the mediastinum. Radiol Clin North Am. 2021.

Abstracts

1. Carter BW, Schlott-Gaur LS, Lukyanchenko O, Benamar A, Tannir H, Hicks ME. Patient Safety Event Reporting in Diagnostic Imaging at a Comprehensive Cancer Center. Radiological Society of North America Annual Meeting, 2020. e-Pub 2020.
2. Ferreira Dalla Pria HR, Pokhylevych, Tonso VM, Hassan AA, Saleh MM, Carter BW, Bhosale PR. Understanding Tumor Metrics in Neuro-Oncology – It's Easy Until It’s Not!. Radiological Society of North America Annual Meeting, 2020. e-Pub 2020.
3. Carter BW, Schlott-Gaur LS, Lukyanchenko O, Benamar A, Tannir H, Hicks ME. Patient Safety Event Reporting in Diagnostic Imaging at a Comprehensive Cancer Center, 2020. e-Pub 2020.
4. Ferreira Dalla Pria HR, Pokhylevych, Tonso VM, Hassan AA, Saleh MM, Carter BW, Bhosale PR. Understanding Tumor Metrics in Neuro-Oncology – It's Easy Until It’s Not!, 2020. e-Pub 2020.
5. Patel SP, Carter BW, Murthy R, Sheth R, Agarwala SS, Lu G, Redstone E, Balmes GC, Rider H, Rodrigues D, Wachter EA. Percutaneous hepatic injection of rose bengal disodium (PV-10) in metastatic uveal melanoma. American Society of Clinical Oncology Annual Meeting, 2020. e-Pub 2020.
6. Li J, Wang Y, Tang C, Welsh JW, Guha-Thakurta N, Carter BW, Wefel JS, Ghia AJ, Yeboa D, McAleer MF, Chung C, Woodhouse KD, Elamin Y, Le X, Cascone T, Negrao MV, Skoulidis F, Ferrarotto R, Heymach J, Altan M. Concurrent nivolumab and ipilimumab with brain stereotactic radiosurgery for brain metastases from non-small cell lung cancer: A phase I trial. American Society of Clinical Oncology Annual Meeting, 2020. e-Pub 2020.
7. Alessi JVM, Ricciuti B, Aguilar EJ, Hong F, Wei Z, Nishino M, Plodkowski AJ, Sawan P, Luo J, Rizvi H, Carter BW, Heymach J, Altan A, Hellmann MD, Awad MM. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small-cell lung cancer and a poor performance status. American Society of Clinical Oncology Annual Meeting, 2020. e-Pub 2020.
8. Patel SP, Carter BW, Murthy R, Sheth R, Agarwala SS, Lu G, Redstone E, Balmes GC, Rider H, Rodrigues D, Wachter EA. Percutaneous hepatic injection of rose bengal disodium (PV-10) in metastatic uveal melanoma, 2020. e-Pub 2020.
9. Alessi JVM, Ricciuti B, Aguilar EJ, Hong F, Wei Z, Nishino M, Plodkowski AJ, Sawan P, Luo J, Rizvi H, Carter BW, Heymach J, Altan A, Hellmann MD, Awad MM. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small-cell lung cancer and a poor performance status, 2020. e-Pub 2020.
10. Li J, Wang Y, Tang C, Welsh JW, Guha-Thakurta N, Carter BW, Wefel JS, Ghia AJ, Yeboa D, McAleer MF, Chung C, Woodhouse KD, Elamin Y, Le X, Cascone T, Negrao MV, Skoulidis F, Ferrarotto R, Heymach J, Altan M. Concurrent nivolumab and ipilimumab with brain stereotactic radiosurgery for brain metastases from non-small cell lung cancer: A phase I trial, 2020. e-Pub 2020.
11. Carter BW, Schlott-Gaur LS, Lukyanchenko O, Tannir H, Hicks ME. Transition from Faculty Peer Review to Peer Learning in Diagnostic Imaging at a Tertiary Cancer Center. International Forum on Quality and Safety in Health Care, Copenhagen, Denmark, 2020. e-Pub 2020.
12. Carter BW, Schlott-Gaur LS, Lukyanchenko O, Tannir H, Hicks ME. Reduction in Patient Falls in Diagnostic Imaging at a Tertiary Cancer Center. International Forum on Quality and Safety in Health Care, Copenhagen, Denmark, 2020. e-Pub 2020.
13. Carter BW, Schlott-Gaur LS, Lukyanchenko O, Tannir H, Hicks ME. Transition from Faculty Peer Review to Peer Learning in Diagnostic Imaging at a Tertiary Cancer Center, 2020. e-Pub 2020.
14. Carter BW, Schlott-Gaur LS, Lukyanchenko O, Tannir H, Hicks ME. Reduction in Patient Falls in Diagnostic Imaging at a Tertiary Cancer Center, 2020. e-Pub 2020.
15. Moawad A, Fuentes D, Elbanan M, Carter BW, Garg N, Rauch GM, Vining D, Elsayes K. Artificial Intelligence in Diagnostic Imaging: Current Applications and Future Perspective. Radiological Society of North America Annual Meeting, 2019. e-Pub 2019.
16. Lee GM, Stowell J, Carter BW, Pope KL, Meek LJ, Walker C. Thoracic lymphatic metastases from extra-pulmonary malignancies: predictable patterns of spread. Radiological Society of North America Annual Meeting, 2019. e-Pub 2019.
17. Carter BW, Murthy R, Balmes G, Wachter EA, Patel SP. Response Assessment of Metastatic Uveal Melanoma Treated with Rose Bengal Disodium. European Society of Medical Oncology Immuno-Oncology Congress, Geneva, Switzerland, 2019. e-Pub 2019.
18. Lee GM, Stowell J, Carter BW, Pope KL, Meek LJ, Walker C. Thoracic lymphatic metastases from extra-pulmonary malignancies: predictable patterns of spread, 2019. e-Pub 2019.
19. Moawad A, Fuentes D, Elbanan M, Carter BW, Garg N, Rauch GM, Vining D, Elsayes K. Artificial Intelligence in Diagnostic Imaging: Current Applications and Future Perspective, 2019. e-Pub 2019.
20. Carter BW, Murthy R, Balmes G, Wachter EA, Patel SP. Response Assessment of Metastatic Uveal Melanoma Treated with Rose Bengal Disodium, 2019. e-Pub 2019.
21. Tran H, Lam V, Vasquez M, Hong L, Colen R, Elshafeey N, Hassan I, Papadimitrakopoulou VA, Blumenschein G, Carter BW, Simon GR, Lanman RB, Raymond V, Elamin Y, Altan M, Tsao A, Gibbons DL, Zhang J, Heymach JV. Outcomes in Advanced NSCLC Patients Treated with 1st Line EGFR-TKI Based on Mutation Detection from Tissue or cfDNA-Based Genomic Sequencing. World Conference on Lung Cancer Annual Meeting, 2019. e-Pub 2019.
22. Skoulidis F, Arbour KC, Hellmann M, Patil PD, Marmarelis ME, Owen DH, Awad M, Murray JC, Levy BP, Hellyer J, Gainor JF, Stewart T, Goldberg SB, Dimou A, Bestvina CM, Cummings AL, Elamin Y, Lam V, Zhang J, Shu C, Riess JW, Blakely CM, Pecot CV, Mezquita L, Tabbo F, Sacher AG, Scheffler M, Ricciuti B, Venkatraman D, Rizvi H, Liu C, Johnston RP, Ni Y, Azok J, Kier MW, Katz SI, Davies KD, Segal JP, Ritterhouse L, Shaish H, Memmott R, Carter BW, Woodcock M, Roth J, Swisher S, Leighl NB, Digumarthy S, Mooradian M, Rotow J, Wolf J, Scagliotti GV, Planchard D, Besse B, Bivona TG, Gandara DR, Garon E, Rivzi NA, Camidge R, Schalper KA, Herbst RS, Shaw AT, Neal JW, Wakalee HA, Brahmer JR, Janne PA, Carbone DP, Aggarwal C, Pennell N, Rudin CM, Papadimitrakopoulou VA, Heymach JV. STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinica Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC. World Conference on Lung Cancer Annual Meeting, 2019. e-Pub 2019.
23. Skoulidis F, Arbour KC, Hellmann M, Patil PD, Marmarelis ME, Owen DH, Awad M, Murray JC, Levy BP, Hellyer J, Gainor JF, Stewart T, Goldberg SB, Dimou A, Bestvina CM, Cummings AL, Elamin Y, Lam V, Zhang J, Shu C, Riess JW, Blakely CM, Pecot CV, Mezquita L, Tabbo F, Sacher AG, Scheffler M, Ricciuti B, Venkatraman D, Rizvi H, Liu C, Johnston RP, Ni Y, Azok J, Kier MW, Katz SI, Davies KD, Segal JP, Ritterhouse L, Shaish H, Memmott R, Carter BW, Woodcock M, Roth J, Swisher S, Leighl NB, Digumarthy S, Mooradian M, Rotow J, Wolf J, Scagliotti GV, Planchard D, Besse B, Bivona TG, Gandara DR, Garon E, Rivzi NA, Camidge R, Schalper KA, Herbst RS, Shaw AT, Neal JW, Wakalee HA, Brahmer JR, Janne PA, Carbone DP, Aggarwal C, Pennell N, Rudin CM, Papadimitrakopoulou VA, Heymach JV. STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinica Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC, 2019. e-Pub 2019.
24. Tran H, Lam V, Vasquez M, Hong L, Colen R, Elshafeey N, Hassan I, Papadimitrakopoulou VA, Blumenschein G, Carter BW, Simon GR, Lanman RB, Raymond V, Elamin Y, Altan M, Tsao A, Gibbons DL, Zhang J, Heymach JV. Outcomes in Advanced NSCLC Patients Treated with 1st Line EGFR-TKI Based on Mutation Detection from Tissue or cfDNA-Based Genomic Sequencing, 2019. e-Pub 2019.
25. Elamin Y, Robichaux JP, Carter BW, Altan M, Gibbons DL, Fossella F, Simon GR, Lam V, Blumenschein G, Tsao A, Kurie J, Mott FE, Vailati Negrao M, Hu L, He J, Nilsson M, Roeck B, Yang Z, Papadimitrakopoulou VA, Heymach JV. Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer. World Conference on Lung Cancer Annual Meeting, 2018. e-Pub 2018.
26. Shroff GS, Shroff S, Ocazionez D, Supsupin EP, Carter BW, Wu CC, Kaya D, Price M. It's Not All in Your Head: Thoracic Manifestations of Neurologic Diseases and Disorders. Radiological Society of North America Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
27. Shroff GS, Shroff S, Ocazionez D, Supsupin EP, Carter BW, Wu CC, Kaya D, Price M. It's Not All in Your Head: Thoracic Manifestations of Neurologic Diseases and Disorders, 2018. e-Pub 2018.
28. Elamin Y, Robichaux JP, Carter BW, Altan M, Gibbons DL, Fossella F, Simon GR, Lam V, Blumenschein G, Tsao A, Kurie J, Mott FE, Vailati Negrao M, Hu L, He J, Nilsson M, Roeck B, Yang Z, Papadimitrakopoulou VA, Heymach JV. Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer, 2018. e-Pub 2018.
29. Heymach J, Negrao M, Robichaux J, Carter BW, Patel A, Altan M, Gibbons D, Fossella F, Simon G, Lam V, Blumenschein G, Tsao A, Kurie J, Mott F, Jenkins D, Mack D, Feng L, Roeck B, Yang Y, Papadimitrakopoulou V, Elamin Y. A Phase II Trial of Poziotinib in EGFR and HER2 Exon 20 Mutant Non-Small Cell Lung Cancer. World Conference on Lung Cancer Annual Meeting, 2018. e-Pub 2018.
30. Tran H, Lam V, Vasquez M, Hong L, Colen R, Elshafeey N, Hassan I, Prado E, Papadimitrakopoulou V, Blumenschein G, Carter BW, Simon G, Byers L, Altan M, Elamin Y, Lanman R, Raymond V, Tsao A, Gibbons D, Fossella F, Zhang J, Heymach J. Clinical Evaluation of Plasma-Based (CFDNA) Genomic Profiling in Over 1,000 Patients with Advanced Non-Small Cell Lung Cancer. American Roentgen Ray Society Annual Meeting, 2018. e-Pub 2018.
31. Heymach J, Negrao M, Robichaux J, Carter BW, Patel A, Altan M, Gibbons D, Fossella F, Simon G, Lam V, Blumenschein G, Tsao A, Kurie J, Mott F, Jenkins D, Mack D, Feng L, Roeck B, Yang Y, Papadimitrakopoulou V, Elamin Y. A Phase II Trial of Poziotinib in EGFR and HER2 Exon 20 Mutant Non-Small Cell Lung Cancer, 2018. e-Pub 2018.
32. Tran H, Lam V, Vasquez M, Hong L, Colen R, Elshafeey N, Hassan I, Prado E, Papadimitrakopoulou V, Blumenschein G, Carter BW, Simon G, Byers L, Altan M, Elamin Y, Lanman R, Raymond V, Tsao A, Gibbons D, Fossella F, Zhang J, Heymach J. Clinical Evaluation of Plasma-Based (CFDNA) Genomic Profiling in Over 1,000 Patients with Advanced Non-Small Cell Lung Cancer, 2018. e-Pub 2018.
33. Skoulidis, Carter BW, Chang J, Wistuba II, Papadimitrakopoulou V, Heymach J. Association of STK11/LKB1 Mutations with Primary Resistance to PD-1/OD-L1 Axis Blockade in PD-L1 Positive Non-Squamous NSCLC. American Roentgen Ray Society Annual Meeting, 2018. e-Pub 2018.
34. Skoulidis, Carter BW, Chang J, Wistuba II, Papadimitrakopoulou V, Heymach J. Association of STK11/LKB1 Mutations with Primary Resistance to PD-1/OD-L1 Axis Blockade in PD-L1 Positive Non-Squamous NSCLC, 2018. e-Pub 2018.
35. Shroff GS, Carter BW, Chiles C, Munden RF, Truong MT. Lessons from Thoracic Oncologic Multidisciplinary Conference: What the Radiologist Needs to Know. American Roentgen Ray Society Annual Meeting, 2018. e-Pub 2018.
36. Shroff GS, Carter BW, Chiles C, Munden RF, Truong MT. Lessons from Thoracic Oncologic Multidisciplinary Conference: What the Radiologist Needs to Know, 2018. e-Pub 2018.
37. Betancourt SL, Benveniste MF, Palacio D, Hofstetter W, Carter BW, Erasmus JJ. TNM staging system for esophageal cancer: what is new. Radiological Society of North America Annual Meeting, 2017. e-Pub 2017.
38. Shroff GS, Viswanathan C, Truong MT, Carter BW, Sabloff BS, Chiles C, Erasmus JE, Munden RF. Lessons from thoracic oncologic multidisciplinary conference: what the radiologist needs to know. Radiological Society of North America Annual Meeting, 2017. e-Pub 2017.
39. Benveniste MF, Carter BW, Betancourt SL, Shroff G, Odisio E, Marom EM. The good the bad and the ugly: recognizing thoracic radiotherapy complications. Radiological Society of North America Annual Meeting, 2017. e-Pub 2017.
40. Shroff GS, Wu CC, Benveniste MK, Carter BW, Viswanathan C, Truong MT. The many faces of leukemia in the thorax. Radiological Society of North America Annual Meeting, 2017. e-Pub 2017.
41. Shroff GS, Viswanathan C, Truong MT, Carter BW, Sabloff BS, Chiles C, Erasmus JE, Munden RF. Lessons from thoracic oncologic multidisciplinary conference: what the radiologist needs to know, 2017. e-Pub 2017.
42. Benveniste MF, Carter BW, Betancourt SL, Shroff G, Odisio E, Marom EM. The good the bad and the ugly: recognizing thoracic radiotherapy complications, 2017. e-Pub 2017.
43. Betancourt SL, Benveniste MF, Palacio D, Hofstetter W, Carter BW, Erasmus JJ. TNM staging system for esophageal cancer: what is new, 2017. e-Pub 2017.
44. Shroff GS, Wu CC, Benveniste MK, Carter BW, Viswanathan C, Truong MT. The many faces of leukemia in the thorax, 2017. e-Pub 2017.
45. Variyam DE, Badugu P, Ghaly F, Carter BW, Yeung SJ, Rice TW, Halm J, Steele J, Wu CC. Performance of guideline-based evaluation of suspected pulmonary embolus at a large cancer center. 4th World Congress of Thoracic Imaging, Boston, MA, 2017. e-Pub 2017.
46. Ferrarotto F, Duran AH, Wei W, Carter BW, El-Naggar AK, Su SY, Bell D, Kies MS, William WN, Glisson BS, Godoy M, Heymach J. Association of activating NOTCH1 mutations in adenoid cystic carcinoma with shorter progression-free survival to systemic therapy. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2017. e-Pub 2017.
47. Naing A, Fu S, Tsimberidou AM, Pant S, Piha-Paul SA, Janku F, Hong DS, Colen RR, Carter BW, Evans W, Tawbi H, Karp DD, Subbiah V, Dev R, Hess KR, Ueno NT, Simon GR, Overman MJ, Coleman RL, Meric-Bernstam F. Phase IB study to evaluate the safety of selinexor in combination with multiple standard chemotherapy agents in patients with advanced malignancies. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2017. e-Pub 2017.
48. Carter BW, Wu CC. Analysis of free-form radiology dictations for completeness and clarity for reporting of pulmonary embolism. 4th World Congress of Thoracic Imaging, Boston, MA, 2017. e-Pub 2017.
49. Skoulidis F, Hellmann MD, Awad MM, Rizvi H, Carter BW, Denning W, Elamin Y, Zhang Y, Leonardi GC, Halpenny D, Plodkowski A, Long N, Erasmus JJ, Papadimitrakopoulou V, Wong KK, Wistuba II, Janne PA, Rudin CM, Heymach J. STK11/LKB1 co-mutations to predict for de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2017. e-Pub 2017.
50. Skoulidis F, Hellmann MD, Awad MM, Rizvi H, Carter BW, Denning W, Elamin Y, Zhang Y, Leonardi GC, Halpenny D, Plodkowski A, Long N, Erasmus JJ, Papadimitrakopoulou V, Wong KK, Wistuba II, Janne PA, Rudin CM, Heymach J. STK11/LKB1 co-mutations to predict for de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma, 2017. e-Pub 2017.
51. Naing A, Fu S, Tsimberidou AM, Pant S, Piha-Paul SA, Janku F, Hong DS, Colen RR, Carter BW, Evans W, Tawbi H, Karp DD, Subbiah V, Dev R, Hess KR, Ueno NT, Simon GR, Overman MJ, Coleman RL, Meric-Bernstam F. Phase IB study to evaluate the safety of selinexor in combination with multiple standard chemotherapy agents in patients with advanced malignancies, 2017. e-Pub 2017.
52. Variyam DE, Badugu P, Ghaly F, Carter BW, Yeung SJ, Rice TW, Halm J, Steele J, Wu CC. Performance of guideline-based evaluation of suspected pulmonary embolus at a large cancer center, 2017. e-Pub 2017.
53. Ferrarotto F, Duran AH, Wei W, Carter BW, El-Naggar AK, Su SY, Bell D, Kies MS, William WN, Glisson BS, Godoy M, Heymach J. Association of activating NOTCH1 mutations in adenoid cystic carcinoma with shorter progression-free survival to systemic therapy, 2017. e-Pub 2017.
54. Carter BW, Wu CC. Analysis of free-form radiology dictations for completeness and clarity for reporting of pulmonary embolism, 2017. e-Pub 2017.
55. Benveniste MF, Carter BW, Shroff G, Truong MT, Sun J, Marom EM. Diffusion-weighted MR imaging for assessment of mediastinal masses. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
56. Assing M, Salem U, Caracciolo J, Gage K, Carter BW, Jeong D. MRI in the evaluation of oncologic chest disease: conventional and emerging applications. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
57. Carter BW, Wargo J, Amaria R, Bhosale P, Elbanan M, Duran E, Unlu E, Wei W, Sun J, Fuentes D, Yang W. RECIST 1.1 criteria and quantitative CT image features to predict pathologic response to immunotherapy in melanoma: preliminary findings. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
58. Salem U, Madewell J, Behrang A, Carter BW. Modern imaging of the brachial plexus: techniques and pathologies. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
59. Price M, Gilman M, Carter BW, Truong MR, Shepard JO. Manifestations of eosinophilic diseases of the lung. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
60. Carter BW, Lichtenberger JP, Wu CC, de Groot PM, Truong MT. Proposed revisions to the TNM staging system (TNM-8) for lung cancer: rationale, significance, and clinical application. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
61. Salem U, Madewell J, Behrang A, Carter BW. Modern imaging of the brachial plexus: techniques and pathologies, 2016. e-Pub 2016.
62. Benveniste MF, Carter BW, Shroff G, Truong MT, Sun J, Marom EM. Diffusion-weighted MR imaging for assessment of mediastinal masses, 2016. e-Pub 2016.
63. Assing M, Salem U, Caracciolo J, Gage K, Carter BW, Jeong D. MRI in the evaluation of oncologic chest disease: conventional and emerging applications, 2016. e-Pub 2016.
64. Price M, Gilman M, Carter BW, Truong MR, Shepard JO. Manifestations of eosinophilic diseases of the lung, 2016. e-Pub 2016.
65. Carter BW, Wargo J, Amaria R, Bhosale P, Elbanan M, Duran E, Unlu E, Wei W, Sun J, Fuentes D, Yang W. RECIST 1.1 criteria and quantitative CT image features to predict pathologic response to immunotherapy in melanoma: preliminary findings, 2016. e-Pub 2016.
66. Carter BW, Lichtenberger JP, Wu CC, de Groot PM, Truong MT. Proposed revisions to the TNM staging system (TNM-8) for lung cancer: rationale, significance, and clinical application, 2016. e-Pub 2016.
67. Mandan R, Carter BW, Ackman JB. Cystic mediastinal masses and the role of MRI. American Roentgen Ray Society Annual Meeting, 2016. e-Pub 2016.
68. Carter BW, Erasmus JJ, Truong MT. Advanced imaging of thoracic malignancies. MD Anderson Cancer Center Global Academic Programs, 2016. e-Pub 2016.
69. Carter BW, Godoy MCB, Erasmus JJ. Lung cancer update: proposed staging revisions. American Roentgen Ray Society Annual Meeting, 2016. e-Pub 2016.
70. Rao S, Elbanan M, Iyer R, Nellippallil R, Mulpur K, BW . Improved clinical decision making through standardized capture and analysis of imaging data. MD Anderson Cancer Center Global Academic Programs, Brazil, 2016. e-Pub 2016.
71. Carter BW, Benveniste MF. Modern imaging of the prevascular mediastinum. American Roentgen Ray Society Annual Meeting, 2016. e-Pub 2016.
72. Betancourt SL, Carter BW, Marom EM. Beyond the ordinary: the other esophageal tumors. American Roentgen Ray Society Annual Meeting, 2016. e-Pub 2016.
73. Carter BW, Godoy MCB, Erasmus JJ. Lung cancer update: proposed staging revisions, 2016. e-Pub 2016.
74. Carter BW, Benveniste MF. Modern imaging of the prevascular mediastinum, 2016. e-Pub 2016.
75. Betancourt SL, Carter BW, Marom EM. Beyond the ordinary: the other esophageal tumors, 2016. e-Pub 2016.
76. Carter BW, Erasmus JJ, Truong MT. Advanced imaging of thoracic malignancies, 2016. e-Pub 2016.
77. Mandan R, Carter BW, Ackman JB. Cystic mediastinal masses and the role of MRI, 2016. e-Pub 2016.
78. Rao S, Elbanan M, Iyer R, Nellippallil R, Mulpur K, BW . Improved clinical decision making through standardized capture and analysis of imaging data, 2016. e-Pub 2016.
79. Betancourt SL, Benveniste MF, Carter BW, Godoy MCB, Wu CC, Palacio D. Clinical usefulness of FDG PET/CT for detection of recurrence in patients with esophageal carcinoma after surgical resection. Society of Thoracic Radiology Annual Meeting, Scottsdale, AZ, 2016. e-Pub 2016.
80. Benveniste MF, Gomez D, Carter BW, Betancourt SL, de Groot PM, Marom EM. Multimodality imaging of mediastinal abnormalities following radiotherapy. Society of Thoracic Radiology Annual Meeting, Scottsdale, AZ, 2016. e-Pub 2016.
81. de Groot PM, Tang C, Godoy MCB, Welsh J, Betancourt SL, Carter BW. Manning the front lines: immunotherapy and ir-response criteria in the treatment of lung cancer. Society of Thoracic Radiology Annual Meeting, Scottsdale, AZ, 2016. e-Pub 2016.
82. Odisio EL, Erasmus JJ, Carter BW, Wu CC, Betancourt SL, Godoy MCB. Multimodality imaging approach, staging and therapy assessment of esophageal cancer. Society of Thoracic Radiology Annual Meeting, Scottsdale, AZ, 2016. e-Pub 2016.
83. Golshani A, Shroff G, Garza A, Carter BW, Patel J, Patel M, Nachiappan A, Akanti B, Gregoric I, Ocazionez D. Follow that lead: a step beyond pacers and AICDs: a radiographic, photographic, and CT correlation of modern cardiac devices. Society of Thoracic Radiology Annual Meeting, Scottsdale, AZ, 2016. e-Pub 2016.
84. de Groot PM, Tang C, Godoy MCB, Welsh J, Betancourt SL, Carter BW. Manning the front lines: immunotherapy and ir-response criteria in the treatment of lung cancer, 2016. e-Pub 2016.
85. Benveniste MF, Gomez D, Carter BW, Betancourt SL, de Groot PM, Marom EM. Multimodality imaging of mediastinal abnormalities following radiotherapy, 2016. e-Pub 2016.
86. Odisio EL, Erasmus JJ, Carter BW, Wu CC, Betancourt SL, Godoy MCB. Multimodality imaging approach, staging and therapy assessment of esophageal cancer, 2016. e-Pub 2016.
87. Golshani A, Shroff G, Garza A, Carter BW, Patel J, Patel M, Nachiappan A, Akanti B, Gregoric I, Ocazionez D. Follow that lead: a step beyond pacers and AICDs: a radiographic, photographic, and CT correlation of modern cardiac devices, 2016. e-Pub 2016.
88. Betancourt SL, Benveniste MF, Carter BW, Godoy MCB, Wu CC, Palacio D. Clinical usefulness of FDG PET/CT for detection of recurrence in patients with esophageal carcinoma after surgical resection, 2016. e-Pub 2016.
89. Carter BW, Erasmus JJ, Truong MT, Munden RF, Shepard JO, Clarke R, Steele J. Quality and value of subspecialty reinterpretation of outside thoracic CT scans of patients referred to a tertiary cancer center. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
90. Carter BW, Erasmus JJ, Truong MT, Munden RF, Shepard JO, Clarke R, Steele J. Quality and value of subspecialty reinterpretation of outside thoracic CT scans of patients referred to a tertiary cancer center, 2016. e-Pub 2016.
91. Carter BW. Thoracic oncologic imaging: treatment effects and complications. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
92. Carter BW, Benveniste MK, Wu C, de Groot PM, Truong M. Proposed revisions to the TNM staging system (TNM-8) for lung cancer: rationale, significance, and clinical application. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
93. Carter BW, Yang W, Bhosale P, Rao S, Elbanan W, Fuentes D, Duran A, Unlu E, Wei W, Sun J, Wargo J. RECIST 1.1 criteria and quantitative CT image features to predict pathologic response to immunotherapy in melanoma: preliminary findings. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
94. Carter BW. Imaging of thoracic neoplasms (2016 update): an interactive session. Radiological Society of North America Annual Meeting, 2016. e-Pub 2016.
95. Carter BW. Imaging of thoracic neoplasms (2016 update): an interactive session, 2016. e-Pub 2016.
96. Carter BW, Yang W, Bhosale P, Rao S, Elbanan W, Fuentes D, Duran A, Unlu E, Wei W, Sun J, Wargo J. RECIST 1.1 criteria and quantitative CT image features to predict pathologic response to immunotherapy in melanoma: preliminary findings, 2016. e-Pub 2016.
97. Carter BW, Benveniste MK, Wu C, de Groot PM, Truong M. Proposed revisions to the TNM staging system (TNM-8) for lung cancer: rationale, significance, and clinical application, 2016. e-Pub 2016.
98. Carter BW. Thoracic oncologic imaging: treatment effects and complications, 2016. e-Pub 2016.
99. de Groot PM, Betancourt SL, Tang C, Godoy MCB, Welsh J, Carter BW. Mobilizing the troops: irRC in cancer immunotherapy response assessment. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
100. Stowell J, Walker CM, Rosado de Christenson ML, Wu CC, Carter BW, Betancourt SL, Kunin J. Thoracic manifestations of genitourinary malignancies: patterns of spread and treatment-related complications. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
101. Madan R, Selvarajan SK, Carter BW. Postoperative esophageal leaks and mimics: finding “the one” which sinks the ship. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
102. Shroff G, Carter BW, Viswanathan C, Marom EM, Wu CC, Truong MT. Challenges in interpretation of staging PET/CT in thoracic malignancies. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
103. Carter BW, Benveniste M, Madan R, de Groot PM, Godoy MCB, Truong MT, Marom EM. New ITMIG classification of mediastinal compartments: update and approach to mediastinal masses. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
104. de Groot PM, Osidio EG, Carter BW, Rice D. Tracheobronchial malignancies: current concepts in minimally invasive intervention and surgical resection. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
105. Sorensen J, Erasmus JJ, Patel SS, Court LA, Godoy MCB, Carter BW, Lee J, Gold K, Swisher S, Heymach J. Radiogenomic detection of EGFR and KRAS mutations in NSCLC using CT texture analysis. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
106. Carter BW, Benveniste MF, Madan R, de Groot PM, Godoy MCB, Truong MT, Marom EM. Update on mediastinal imaging: proposed ITMIG/IASLC staging system and lymph node map for thymic epithelial neoplasms. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
107. Godoy MCB, Osidio EG, Carter BW, Truong MT, Chiles C, Gladish G. Incidental findings in lung cancer CT screening: which ones are relevant?. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
108. Osidio EG, Erasmus JJ, Carter BW, Chate R, Passalaqua S, Godoy MCB, Santos R. Understanding Lung- RADS™: a practical approach. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
109. Godoy MCB, Osidio EG, Carter BW, Truong MT, Chiles C, Gladish G. Incidental findings in lung cancer CT screening: which ones are relevant?, 2015. e-Pub 2015.
110. Osidio EG, Erasmus JJ, Carter BW, Chate R, Passalaqua S, Godoy MCB, Santos R. Understanding Lung- RADS™: a practical approach, 2015. e-Pub 2015.
111. Madan R, Selvarajan SK, Carter BW. Postoperative esophageal leaks and mimics: finding “the one” which sinks the ship, 2015. e-Pub 2015.
112. de Groot PM, Betancourt SL, Tang C, Godoy MCB, Welsh J, Carter BW. Mobilizing the troops: irRC in cancer immunotherapy response assessment, 2015. e-Pub 2015.
113. Shroff G, Carter BW, Viswanathan C, Marom EM, Wu CC, Truong MT. Challenges in interpretation of staging PET/CT in thoracic malignancies, 2015. e-Pub 2015.
114. Carter BW, Benveniste M, Madan R, de Groot PM, Godoy MCB, Truong MT, Marom EM. New ITMIG classification of mediastinal compartments: update and approach to mediastinal masses, 2015. e-Pub 2015.
115. Stowell J, Walker CM, Rosado de Christenson ML, Wu CC, Carter BW, Betancourt SL, Kunin J. Thoracic manifestations of genitourinary malignancies: patterns of spread and treatment-related complications, 2015. e-Pub 2015.
116. de Groot PM, Osidio EG, Carter BW, Rice D. Tracheobronchial malignancies: current concepts in minimally invasive intervention and surgical resection, 2015. e-Pub 2015.
117. Sorensen J, Erasmus JJ, Patel SS, Court LA, Godoy MCB, Carter BW, Lee J, Gold K, Swisher S, Heymach J. Radiogenomic detection of EGFR and KRAS mutations in NSCLC using CT texture analysis, 2015. e-Pub 2015.
118. Carter BW, Benveniste MF, Madan R, de Groot PM, Godoy MCB, Truong MT, Marom EM. Update on mediastinal imaging: proposed ITMIG/IASLC staging system and lymph node map for thymic epithelial neoplasms, 2015. e-Pub 2015.
119. Betancourt SL, Martinez-Jimenez S, Palacio DM, Hofstetter WL, Carter BW, Marom EM. Soft Tissue and chest wall reconstruction after intrathoracic oncological resections. Radiological Society of North America Annual Meeting, 2015. e-Pub 2015.
120. Benveniste MF, Betancourt Cuellar SL, Truong MT, Sabloff B, Carter BW, Marom EM. Comparison between CT and MRI in preoperative evaluation of thymic epithelial tumors. International Thymic Malignancy Interest Group Annual Meeting, Shanghai, China, 2015. e-Pub 2015.
121. Benveniste MF, Betancourt Cuellar SL, Truong MT, Sabloff B, Carter BW, Marom EM. Comparison between CT and MRI in preoperative evaluation of thymic epithelial tumors, 2015. e-Pub 2015.
122. Betancourt SL, Martinez-Jimenez S, Palacio DM, Hofstetter WL, Carter BW, Marom EM. Soft Tissue and chest wall reconstruction after intrathoracic oncological resections, 2015. e-Pub 2015.
123. Godoy MCB, Carter BW, Erasmus JJ. Advanced CT imaging of patients treated with immunotherapy for lung cancer. MD Anderson GAP Young Investigator Workshop, Oslo, Norway, 2015. e-Pub 2015.
124. Carter BW, Godoy MC, Erasmus JJ. Quantitative imaging and radiogenomics of lung cancer. MD Anderson GAP Young Investigator Workshop, Oslo, Norway, 2015. e-Pub 2015.
125. Carter BW, Godoy MC, Erasmus JJ. Quantitative imaging and radiogenomics of lung cancer, 2015. e-Pub 2015.
126. Godoy MCB, Carter BW, Erasmus JJ. Advanced CT imaging of patients treated with immunotherapy for lung cancer, 2015. e-Pub 2015.
127. Yang L, Son JB, Ma J, Cheng S, Hazle J, Carter BW, Lin S. Quantitative ADC measurement of esophageal cancer before and after chemoradiation. American Association of Physicists in Medicine, 2015. e-Pub 2015.
128. Yang L, Son JB, Ma J, Cheng S, Hazle J, Carter BW, Lin S. Quantitative ADC measurement of esophageal cancer before and after chemoradiation, 2015. e-Pub 2015.
129. Holliday EB, Allen PK, Carter BW, Wei X, Bilton, SD, Komaki R. Factors influencing brain recurrence after PCI among patients with limited small cell lung cancer who achieved CR. American Radium Society Annual Meeting, 2015. e-Pub 2015.
130. Komaki R, Allen PK, Wei X, Holliday EB, Carter BW, Bilton SD, Cox JD. Was severe acute esophagitis reduced by the 21st century treatment modalities among patients with limited stage small cell lung cancer?. American Radium Society Annual Meeting, 2015. e-Pub 2015.
131. Holliday EB, Allen PK, Carter BW, Wei X, Bilton, SD, Komaki R. Factors influencing brain recurrence after PCI among patients with limited small cell lung cancer who achieved CR, 2015. e-Pub 2015.
132. Komaki R, Allen PK, Wei X, Holliday EB, Carter BW, Bilton SD, Cox JD. Was severe acute esophagitis reduced by the 21st century treatment modalities among patients with limited stage small cell lung cancer?, 2015. e-Pub 2015.
133. Lichtenberger JP III, Khorashadi L, Carter BW. Metastasis to the heart and pericardium: a radiological approach. American Roentgen Ray Society Annual Meeting, 2015. e-Pub 2015.
134. Carter BW, de Groot PM, Abbott GF, Wu CC. Exploring the pipe: tumors of the tracheobronchial tree and distinguishing imaging features. American Roentgen Ray Society Annual Meeting, 2015. e-Pub 2015.
135. Lichtenberger JP III, Khorashadi L, Carter BW. A nervous breakdown: multimodality imaging of thoracic neurogenic tumors. American Roentgen Ray Society Annual Meeting, 2015. e-Pub 2015.
136. Carter BW, Erasmus JJ. Advanced imaging of intrathoracic malignancies: a multidisciplinary approach. MD Anderson Cancer Center Global Academic Programs, 2015. e-Pub 2015.
137. Carter BW, de Groot PM, Abbott GF, Wu CC. Exploring the pipe: tumors of the tracheobronchial tree and distinguishing imaging features, 2015. e-Pub 2015.
138. Carter BW, Erasmus JJ. Advanced imaging of intrathoracic malignancies: a multidisciplinary approach, 2015. e-Pub 2015.
139. Lichtenberger JP III, Khorashadi L, Carter BW. A nervous breakdown: multimodality imaging of thoracic neurogenic tumors, 2015. e-Pub 2015.
140. Lichtenberger JP III, Khorashadi L, Carter BW. Metastasis to the heart and pericardium: a radiological approach, 2015. e-Pub 2015.
141. Carter BW, Lichtenberger JP III, Truong MT, Wu CC. Incidental findings on CT and PET/CT of the thorax: identification and management. Asian Congress of Thoracic Imaging, Taipei, Taiwan, 2015. e-Pub 2015.
142. Lichtenberger JP III, Khorashadi L, Carter BW. Imaging the post-operative chest wall. Society of Thoracic Radiology Annual Meeting, Carlsbad, CA, 2015. e-Pub 2015.
143. Benveniste MF, Truong M, Sabloff, Betancourt S, Carter BW, Marom EM. Comparison between CT and MRI in preoperative evaluation of thymic epithelial neoplasms. Society of Thoracic Radiology Annual Meeting, Carlsbad, CA, 2015. e-Pub 2015.
144. Carter BW, Lichtenberger JP III, Truong MT, Wu CC. Manifestations of cardiothoracic lymphoma. Asian Congress of Thoracic Imaging, Taipei, Taiwan, 2015. e-Pub 2015.
145. Carter BW, Palacio D, Truong M, Betancourt S. Imaging assessment after multimodality therapy in esophageal carcinoma. Society of Thoracic Radiology Annual Meeting, Carlsbad, CA, 2015. e-Pub 2015.
146. Carter BW, Lichtenberger JP III, Truong MT, Wu CC. Manifestations of cardiothoracic lymphoma, 2015. e-Pub 2015.
147. Carter BW, Lichtenberger JP III, Truong MT, Wu CC. Incidental findings on CT and PET/CT of the thorax: identification and management, 2015. e-Pub 2015.
148. Benveniste MF, Truong M, Sabloff, Betancourt S, Carter BW, Marom EM. Comparison between CT and MRI in preoperative evaluation of thymic epithelial neoplasms, 2015. e-Pub 2015.
149. Lichtenberger JP III, Khorashadi L, Carter BW. Imaging the post-operative chest wall, 2015. e-Pub 2015.
150. Carter BW, Palacio D, Truong M, Betancourt S. Imaging assessment after multimodality therapy in esophageal carcinoma, 2015. e-Pub 2015.
151. Carter BW, Godoy MCB, Abbott GF, Gilman MD, Marom EM, Ko J, Munden RF, Wu CC. When you see more than what you want to see: management of incidental findings on CT or PET/CT of the thorax. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
152. Godoy MCB, Carter BW, de Groot PM, Viswanathan C, Truong MT, Ko JP. Pitfalls in pulmonary nodule characterization. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
153. Betancourt SL, Weissferdt A, Palacio DM, Carter BW, Marom EM. Tracheal lumps and bumps: the good, the bad and the unusual. Radiological Society of North America, 2014. e-Pub 2014.
154. Carter BW, Benveniste MF, Betancourt SL, de Groot PM, Sorensen J, Lichtenberger III JP, Abbott GF. Breaking down the wall: malignant neoplasms of the chest wall and distinguishing imaging features. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
155. Godoy MCB, de Groot PM, Benveniste MK, Carter BW, Marom EM, Truong MT, Abbott GF. Imaging of thoracic infections in the oncologic setting. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
156. Betancourt SL, Palacio DM, Benveniste MK, Carter BW, de Groot PM, Erasmus JJ. Lung cancer: limitations and imaging pitfalls in multimodality staging. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
157. Hassani C, Wu CC, Lee C, Wilcox A, Saremi F, Carter BW. Screening, treatment and post-treatment surveillance of lung cancer: a comprehensive review of current standards. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
158. Benveniste MK, Gomez DR, Carter BW, Betancourt SL, de Groot PM, Marom EM. Proton therapy: what the diagnostic radiologist needs to know. Radiological Society of North America Annual Meeting, 2014. e-Pub 2014.
159. Godoy MCB, Carter BW, de Groot PM, Viswanathan C, Truong MT, Ko JP. Pitfalls in pulmonary nodule characterization, 2014. e-Pub 2014.
160. Betancourt SL, Weissferdt A, Palacio DM, Carter BW, Marom EM. Tracheal lumps and bumps: the good, the bad and the unusual, 2014. e-Pub 2014.
161. Godoy MCB, de Groot PM, Benveniste MK, Carter BW, Marom EM, Truong MT, Abbott GF. Imaging of thoracic infections in the oncologic setting, 2014. e-Pub 2014.
162. Hassani C, Wu CC, Lee C, Wilcox A, Saremi F, Carter BW. Screening, treatment and post-treatment surveillance of lung cancer: a comprehensive review of current standards, 2014. e-Pub 2014.
163. Benveniste MK, Gomez DR, Carter BW, Betancourt SL, de Groot PM, Marom EM. Proton therapy: what the diagnostic radiologist needs to know, 2014. e-Pub 2014.
164. Betancourt SL, Palacio DM, Benveniste MK, Carter BW, de Groot PM, Erasmus JJ. Lung cancer: limitations and imaging pitfalls in multimodality staging, 2014. e-Pub 2014.
165. Carter BW, Benveniste MF, Betancourt SL, de Groot PM, Sorensen J, Lichtenberger III JP, Abbott GF. Breaking down the wall: malignant neoplasms of the chest wall and distinguishing imaging features, 2014. e-Pub 2014.
166. Carter BW, Godoy MCB, Abbott GF, Gilman MD, Marom EM, Ko J, Munden RF, Wu CC. When you see more than what you want to see: management of incidental findings on CT or PET/CT of the thorax, 2014. e-Pub 2014.
167. Carter BW, Tomiyama N, Bhora F, Rosado de Christenson ML, Nakajima J, Boiselle P, Detterbeck FC, Marom EM. ITMIG definition of mediastinal compartments. International Thymic Malignancy Interest Group Annual Meeting, 2014. e-Pub 2014.
168. Benveniste MF, Korst RJ, Rajan A, Detterbeck FC, Carter BW, Marom EM. Radiographic assessment of treatment response of thymic neoplasms using modified RECIST criteria. International Thymic Malignancy Interest Group Annual Meeting, 2014. e-Pub 2014.
169. Carter BW, Okumura M, Benveniste MF, Detterbeck FC, Marom EM. Imaging approach to anterior mediastinal masses. International Thymic Malignancy Interest Group Annual Meeting, 2014. e-Pub 2014.
170. Benveniste MF, Korst RJ, Rajan A, Detterbeck FC, Carter BW, Marom EM. Radiographic assessment of treatment response of thymic neoplasms using modified RECIST criteria, 2014. e-Pub 2014.
171. Carter BW, Okumura M, Benveniste MF, Detterbeck FC, Marom EM. Imaging approach to anterior mediastinal masses, 2014. e-Pub 2014.
172. Carter BW, Tomiyama N, Bhora F, Rosado de Christenson ML, Nakajima J, Boiselle P, Detterbeck FC, Marom EM. ITMIG definition of mediastinal compartments, 2014. e-Pub 2014.
173. Betancourt Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Swisher SG, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal cancer: does FDG-PET/CT have a role?. American Roentgen Ray Society Annual Meeting, 2014. e-Pub 2014.
174. Lichtenberger III JP, Carter BW, Wu CC. Bronchial arteries in thoracic imaging: where they are and what they mean. American Roentgen Ray Society Annual Meeting, 2014. e-Pub 2014.
175. Carter BW, Lichtenberger III JP, Abbott GF, Shepard JO, Wu CC. Lung cancer screening: update and interactive quiz. American Roentgen Ray Society Annual Meeting, 2014. e-Pub 2014.
176. Hassani C, Wu CC, Carter BW, Sharma A. Imaging the lung cancer survivor: optimal timing and modality. American Roentgen Ray Society Annual Meeting, 2014. e-Pub 2014.
177. Carter BW, de Groot PM, Khorashadi L, Truong MT, Wu CC, Lichtenberger III JP. The writing on the wall: tumors of the chest wall and distinguishing imaging features. American Roentgen Ray Society Annual Meeting, 2014. e-Pub 2014.
178. Carter BW, Lichtenberger III JP, Abbott GF, Shepard JO, Wu CC. Lung cancer screening: update and interactive quiz, 2014. e-Pub 2014.
179. Carter BW, de Groot PM, Khorashadi L, Truong MT, Wu CC, Lichtenberger III JP. The writing on the wall: tumors of the chest wall and distinguishing imaging features, 2014. e-Pub 2014.
180. Lichtenberger III JP, Carter BW, Wu CC. Bronchial arteries in thoracic imaging: where they are and what they mean, 2014. e-Pub 2014.
181. Betancourt Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Swisher SG, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal cancer: does FDG-PET/CT have a role?, 2014. e-Pub 2014.
182. Hassani C, Wu CC, Carter BW, Sharma A. Imaging the lung cancer survivor: optimal timing and modality, 2014. e-Pub 2014.
183. Carter BW, de Groot PM, Gilman MD, Sharma A, Abbott GF, Wu CC. Pulmonary arteries great and small: imaging approach to the differential diagnosis. Society of Thoracic Radiology Annual Meeting, 2014. e-Pub 2014.
184. Levine HR, Dockery WD, Tingle E, Carter BW. Synovial metastasis from lung cancer. Texas Radiological Society Annual Meeting, 2014. e-Pub 2014.
185. Lichtenberger III JP, Millard-Hasting BM, McQuillan BF, Carter BW. The interventricular septum: a multimodality analysis of anatomy and pathology. Society of Thoracic Radiology Annual Meeting, 2014. e-Pub 2014.
186. de Groot PM, Godoy MCB, Carter BW, Munden RF, Rice D. Surgical concepts in diffuse pleural malignancies: what the radiologist needs to know. Society of Thoracic Radiology Annual Meeting, 2014. e-Pub 2014.
187. Carter BW, Truong MT, Viswanathan C, Marom EM, Erasmus JJ. Pitfalls in the interpretation of PET/CT findings in the chest. Society of Thoracic Radiology Annual Meeting, 2014. e-Pub 2014.
188. de Groot PM, Godoy MCB, Carter BW, Munden RF, Rice D. Surgical concepts in diffuse pleural malignancies: what the radiologist needs to know, 2014. e-Pub 2014.
189. Carter BW, Truong MT, Viswanathan C, Marom EM, Erasmus JJ. Pitfalls in the interpretation of PET/CT findings in the chest, 2014. e-Pub 2014.
190. Carter BW, de Groot PM, Gilman MD, Sharma A, Abbott GF, Wu CC. Pulmonary arteries great and small: imaging approach to the differential diagnosis, 2014. e-Pub 2014.
191. Lichtenberger III JP, Millard-Hasting BM, McQuillan BF, Carter BW. The interventricular septum: a multimodality analysis of anatomy and pathology, 2014. e-Pub 2014.
192. Levine HR, Dockery WD, Tingle E, Carter BW. Synovial metastasis from lung cancer, 2014. e-Pub 2014.
193. Carter BW, Chasen B, de Groot PM, Chasen MH. Collateral networks in states of congenital absence of major thoracic veins. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
194. Carter BW, Betancourt Cuellar SL, Godoy MC, Mawlawi OR, Marom EM, Truong MT. The role of PET/CT in assessing response to therapy in lung cancer. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
195. Carter BW, Lichtenberger III JP, Khorashadi L, Sabloff BS, Abbott GF, Wu CC. Pulmonary embolism and beyond: congenital and acquired abnormalities of the pulmonary arteries. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
196. Carter BW, Lichtenberger III JP, Khorashadi L, Sabloff BS, Abbott GF, Wu CC. Approach with caution: recognizing vascular masses of the mediastinum. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
197. Betancourt Cuellar SL, Palacio DM, Carter BW, Martinez S, Benveniste MK, Truong MT. CT and PET/CT assessment of complications after chemo and radiation therapy in esophageal carcinoma. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
198. Benveniste A, Carter BW, Benveniste MK, Mawlawi OR, Truong MT, Erasmus, JJ. PERCIST 1.0: PET response evaluation in thoracic malignancies. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
199. Betancourt Cuellar SL, Palacio DM, Carter BW, Martinez S, Benveniste MK, Truong MT. CT and PET/CT assessment of complications after chemo and radiation therapy in esophageal carcinoma, 2013. e-Pub 2013.
200. Carter BW, Chasen B, de Groot PM, Chasen MH. Collateral networks in states of congenital absence of major thoracic veins, 2013. e-Pub 2013.
201. Carter BW, Lichtenberger III JP, Khorashadi L, Sabloff BS, Abbott GF, Wu CC. Approach with caution: recognizing vascular masses of the mediastinum, 2013. e-Pub 2013.
202. Benveniste A, Carter BW, Benveniste MK, Mawlawi OR, Truong MT, Erasmus, JJ. PERCIST 1.0: PET response evaluation in thoracic malignancies, 2013. e-Pub 2013.
203. Carter BW, Betancourt Cuellar SL, Godoy MC, Mawlawi OR, Marom EM, Truong MT. The role of PET/CT in assessing response to therapy in lung cancer, 2013. e-Pub 2013.
204. Carter BW, Lichtenberger III JP, Khorashadi L, Sabloff BS, Abbott GF, Wu CC. Pulmonary embolism and beyond: congenital and acquired abnormalities of the pulmonary arteries, 2013. e-Pub 2013.
205. Ackman JB, Kovacina B, Carter BW, Wu CC, Sharma A, Shepard JA, Halpern EF. Sex difference in normal thymic appearance in adults 20-30 years of age. Radiology 268(1):245-53, 2013. e-Pub 2013. PMID: 23440318.
206. Betancourt SL, Carter BW, Palacio D, Benveniste MFK, Godoy MCB, Marom EM. Imaging interpretation of complications following chest radiation therapy. 3rd World Congress of Thoracic Imaging, 2013. e-Pub 2013.
207. Carter BW, Lichtenberger JP III, Ackman JB, Muse V, Shepard JO, Wu CC. Exploring the pipe: tumors of the tracheobronchial tree and distinguishing imaging features. 3rd World Congress of Thoracic Imaging, 2013. e-Pub 2013.
208. Lichtenberger JP III, Carter BW, Millard-Hasting B, Woods AQ. Thoracic imaging in the combat zone. 3rd World Congress of Thoracic Imaging, 2013. e-Pub 2013.
209. Lichtenberger JP III, Carter BW, Millard-Hasting B, Woods AQ. Blast lung injury: Thoracic imaging manifestations of blast injury in modern war. 3rd World Congress of Thoracic Imaging, 2013. e-Pub 2013.
210. Carter BW, Truong MT, Viswanathan C, Marom EM, Erasmus JJ. Pitfalls in the interpretation of PET/CT findings in the chest. 3rd World Congress of Thoracic Imaging, 2013. e-Pub 2013.
211. Carter BW, Truong MT, Viswanathan C, Marom EM, Erasmus JJ. Pitfalls in the interpretation of PET/CT findings in the chest, 2013. e-Pub 2013.
212. Lichtenberger JP III, Carter BW, Millard-Hasting B, Woods AQ. Blast lung injury: Thoracic imaging manifestations of blast injury in modern war, 2013. e-Pub 2013.
213. Betancourt SL, Carter BW, Palacio D, Benveniste MFK, Godoy MCB, Marom EM. Imaging interpretation of complications following chest radiation therapy, 2013. e-Pub 2013.
214. Carter BW, Lichtenberger JP III, Ackman JB, Muse V, Shepard JO, Wu CC. Exploring the pipe: tumors of the tracheobronchial tree and distinguishing imaging features, 2013. e-Pub 2013.
215. Lichtenberger JP III, Carter BW, Millard-Hasting B, Woods AQ. Thoracic imaging in the combat zone, 2013. e-Pub 2013.
216. Zarghouni M, Lichtenberger JP III, Khorashadi L, Carter BW. NCCN version 1.2013: Pictorial guide to the updated guidelines for lung cancer screening. American Roentgen Ray Society Annual Meeting, 2013. e-Pub 2013.
217. Carter BW, Truong MT, Mawlawi O, Betancourt SL, Marom EM, Erasmus JJ. PERCIST 1.0: PET response evaluation in thoracic malignancies. American Roentgen Ray Society Annual Meeting, 2013. e-Pub 2013.
218. Patel P, Lichtenberger JP III, Khorashadi L, Carter BW. Idiopathic pulmonary hemosiderosis: Spectrum of cardiothoracic imaging findings in the adult patient. American Roentgen Ray Society Annual Meeting, 2013. e-Pub 2013.
219. Patel P, Lichtenberger JP III, Khorashadi L, Carter BW. Idiopathic pulmonary hemosiderosis: Spectrum of cardiothoracic imaging findings in the adult patient, 2013. e-Pub 2013.
220. Zarghouni M, Lichtenberger JP III, Khorashadi L, Carter BW. NCCN version 1.2013: Pictorial guide to the updated guidelines for lung cancer screening, 2013. e-Pub 2013.
221. Carter BW, Truong MT, Mawlawi O, Betancourt SL, Marom EM, Erasmus JJ. PERCIST 1.0: PET response evaluation in thoracic malignancies, 2013. e-Pub 2013.
222. Carter BW, Khorashadi L, Wu CC, Abbott GF, Lichtenberger JP. Imitation is the sincerest form of flattery: Recognizing imaging manifestations of intrathoracic lymphoma. Radiological Society of North America Annual Meeting, 2012. e-Pub 2012.
223. Nickell LT, Lichtenberger JP, Khorashadi L, Abbott GF, Carter BW. A picture is worth a thousand words: Multimodality characterization, classification, and staging of malignant pleural mesothelioma. Radiological Society of North America Annual Meeting, 2012. e-Pub 2012.
224. Nickell LT, Lichtenberger JP, Khorashadi L, Abbott GF, Carter BW. A picture is worth a thousand words: Multimodality characterization, classification, and staging of malignant pleural mesothelioma, 2012. e-Pub 2012.
225. Carter BW, Khorashadi L, Wu CC, Abbott GF, Lichtenberger JP. Imitation is the sincerest form of flattery: Recognizing imaging manifestations of intrathoracic lymphoma, 2012. e-Pub 2012.
226. Steel CJ, Carter BW, Jesinger RA, Lichtenberger JP. Superior vena cava syndrome (SVCS): A multimodality approach to diagnosis and treatment. American Roentgen Ray Society Annual Meeting, 2012. e-Pub 2012.
227. McQuillan BF, Carter BW, Jesinger RA, Lichtenberger JP. The interventricular septum: A multimodality review of anatomy and pathology. American Roentgen Ray Society Annual Meeting, 2012. e-Pub 2012.
228. Parisek SI, Carter BW, Lichtenberger JP. Imaging of thoracic adenopathy and metastatic spread for identification of advanced cancer. American Roentgen Ray Society Annual Meeting, 2012. e-Pub 2012.
229. Parisek SI, Carter BW, Lichtenberger JP. Imaging of thoracic adenopathy and metastatic spread for identification of advanced cancer, 2012. e-Pub 2012.
230. Steel CJ, Carter BW, Jesinger RA, Lichtenberger JP. Superior vena cava syndrome (SVCS): A multimodality approach to diagnosis and treatment, 2012. e-Pub 2012.
231. McQuillan BF, Carter BW, Jesinger RA, Lichtenberger JP. The interventricular septum: A multimodality review of anatomy and pathology, 2012. e-Pub 2012.
232. Wang Y, Carter BW, Muse V, Digumarthy S, Shepard JO, Sharma A. 18 FDG PET-CT after talc pleurodesis: evaluation of pleural and extrapleural lymph nodes. Radiological Society of North America Annual Meeting, 2011. e-Pub 2011.
233. Khorashadi L, Wu CC, Carter BW, Sharma A, Abbott GF, Shepard JO. Senescent or significant: normal vs abnormal thoracic imaging findings in elderly patients. Radiological Society of North America Annual Meeting, 2011. e-Pub 2011.
234. Khorashadi L, Wu CC, Carter BW, Sharma A, Abbott GF, Shepard JO. Senescent or significant: normal vs abnormal thoracic imaging findings in elderly patients, 2011. e-Pub 2011.
235. Wang Y, Carter BW, Muse V, Digumarthy S, Shepard JO, Sharma A. 18 FDG PET-CT after talc pleurodesis: evaluation of pleural and extrapleural lymph nodes, 2011. e-Pub 2011.
236. Khorashadi L, Wu CC, Carter BW, Gilman MD, Shepard JO. The great chameleon: Recognizing different patterns of sarcoidosis. American Roentgen Ray Society Annual Meeting, 2011. e-Pub 2011.
237. Khorashadi L, Wu CC, Carter BW, Gilman MD, Shepard JO. The great chameleon: Recognizing different patterns of sarcoidosis, 2011. e-Pub 2011.
238. Aggarwal A, Carter BW, Correia JJ, Frankfurter A, Hill BT, Kruczynski A, Lobert S. Tubulin isotypes in venorelbine-resistant P388 leukemic cells. American Society for Cell Biology Annual Meeting, 2002. e-Pub 2002.
239. Aggarwal A, Carter BW, Correia JJ, Frankfurter A, Hill BT, Kruczynski A, Lobert S. Tubulin isotypes in venorelbine-resistant P388 leukemic cells. American Society for Cell Biology Annual Meeting, 2002. e-Pub 2002.
240. Carter BW, Carter R, Hays P, Payne A, Schrader M, Young C, McGuire SL. Suppressors of the Aspergillus nidulans nimX2 mutation affect septation, branching, development, and nuclear division. Mississippi Academy of Sciences Annual Meeting, 2000. e-Pub 2000.
241. Hays PL, Carter BW, Carter RL, Payne AM, Schrader MD, Wahrle SE, Young CD, McGuire SL. Genetic and microscopic analysis of the snxC1 mutation of Aspergillus nidulans. Millsaps College Research Symposium, 2000. e-Pub 2000.
242. Carter BW, Carter RL, Pays PL, Payne AM, Schrader MD, Wahrle SE, Young CD, McGuire SL. Genetic analysis of clonable extragenic suppressors of the nimXcdc2 F223L mutation of Aspergillus nidulans. Millsaps College Research Symposium, 2000. e-Pub 2000.
243. Carter BW, Carter RL, Pays PL, Payne AM, Schrader MD, Wahrle SE, Young CD, McGuire SL. Genetic analysis of clonable extragenic suppressors of the nimXcdc2 F223L mutation of Aspergillus nidulans. Millsaps College Research Symposium, 2000. e-Pub 2000.
244. Carter BW, Carter R, Hays P, Payne A, Schrader M, Young C, McGuire SL. Suppressors of the Aspergillus nidulans nimX2 mutation affect septation, branching, development, and nuclear division. Millsaps College Research Symposium, 2000. e-Pub 2000.
245. Hays PL, Carter BW, Carter RL, Payne AM, Schrader MD, Wahrle SE, Young CD, McGuire SL. Genetic and microscopic analysis of the snxC1 mutation of Aspergillus nidulans. Millsaps College Research Symposium, 2000. e-Pub 2000.
246. McGuire SL, Carter BW, Carter RL, Wahrle SE, Young CD, Schrader MD, Lang GA, Roe DL. Extragenic suppressors of the Aspergillus nidulans nimX2 mutation affect nuclear division, branching, septation, and conidiation. Annual Meeting of the American Society for Cell Biology, 1999. e-Pub 1999.
247. McGuire SL, Carter BW, Carter RL, Wahrle SE, Young CD, Schrader MD, Lang GA, Roe DL. Extragenic suppressors of the Aspergillus nidulans nimX2 mutation affect nuclear division, branching, septation, and conidiation. American Society for Cell Biology Annual Meeting, 1999. e-Pub 1999.
248. Carter BW, Wahrle S, Schrader M, Young C, McGuire SL. Identification and analysis of clonable extragenic suppressors of the nimXcdc2 F223L mutation of Aspergillus nidulans. Mississippi Academy of Sciences Annual Meeting, 1999. e-Pub 1999.
249. Schrader MD, Carter BW, Wahrle SW, Young CD, McGuire SL. Generation of extragenic suppressors of a cell cycle mutation of Aspergillus nidulans. Millsaps College Research Symposium, 1999. e-Pub 1999.
250. Wahrle SW, Carter BW, Schrader MD, Young CD, McGuire SL. Phenotypic analysis of Aspergillus nidulans with clonable extragenic suppressors of the nimXcdc2 F223L mutation. Millsaps College Research Symposium, 1999. e-Pub 1999.
251. Carter BW, Wahrle SE, Schrader MD, Young CD, McGuire SL. Genetic analysis and characterization of clonable extragenic suppressors of the nimXcdc2 F223L mutation of Aspergillus nidulans. Millsaps College Research Symposium, 1999. e-Pub 1999.
252. Schrader MD, Carter BW, Wahrle SW, Young CD, McGuire SL. Generation of extragenic suppressors of a cell cycle mutation of Aspergillus nidulans. Millsaps College Research Symposium, 1999. e-Pub 1999.
253. Wahrle SW, Carter BW, Schrader MD, Young CD, McGuire SL. Phenotypic analysis of Aspergillus nidulans with clonable extragenic suppressors of the nimXcdc2 F223L mutation. Millsaps College Research Symposium, 1999. e-Pub 1999.
254. Carter BW, Wahrle S, Schrader M, Young C, McGuire SL. Identification and analysis of clonable extragenic suppressors of the nimXcdc2 F223L mutation of Aspergillus nidulans. Mississippi Academy of Sciences Annual Meeting, 1999. e-Pub 1999.
255. Carter BW, Wahrle SE, Schrader MD, Young CD, McGuire SL. Genetic analysis and characterization of clonable extragenic suppressors of the nimXcdc2 F223L mutation of Aspergillus nidulans. Millsaps College Research Symposium, 1999. e-Pub 1999.

Book Chapters

1. Carter BW. Takayasu Arteritis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
2. Carter BW. Pulmonary Artery Hypertension. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
3. Carter BW. Lobectomy. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
4. Carter BW. Chest Wall Lipoma and Liposarcoma. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
5. Carter BW. Saber Sheath Trachea. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
6. Carter BW. Rounded Atelectasis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
7. Carter BW. Absence of the Pericardium. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
8. Carter BW. Pulmonic Stenosis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
9. Carter BW. Cryptococcosis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
10. Carter BW. Plasmacytoma and Multiple Myeloma. In: Diagnostic Imaging: Chest. Elsevier, 2022.
11. Carter BW. Cardiac Sarcoma. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
12. Carter BW. Fat Embolism. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
13. Carter BW. Castleman Disease. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
14. Carter BW. Aortic Valve Disease. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
15. Carter BW. Valve and Annular Calcification. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
16. CarterBW. Tracheobronchial Papillomatosis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
17. Carter BW. Ventricular Septal Defect. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
18. Carter BW. Cicatricial Atelectasis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
19. Carter BW. Constrictive Bronchilitis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
20. Carter BW. Elastofibroma and Fibromatosis. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
21. Carter BW. Ventricular Calcification. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
22. Carter BW. Lymphadenopathy, Metastatic Disease. In: Diagnostic Imaging: Chest. 3rd Edition, 2022.
23. Carter BW. Pulmonary Artery Sarcome. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
24. Carter BW. Malignant Pleural Mesothelioma. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
25. Carter BW. Atrial Septal Defect. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
26. Carter BW. Mediastinal Vascular Masses. In: Diagnostic Imaging: Chest. 3rd Edition. Elsevier, 2022.
27. Carter BW. Fat-containing Mediastinal Mass. In: Expert DDx Chest 2. Elsevier, 2020.
28. Carter BW. Approach to Chest Wall and Diaphragm. In: Expert DDx Chest 2. Elsevier, 2020.
29. Carter BW. Posterior/Paravertebral Mass. In: Expert DDx Chest 2. Elsevier, 2020.
30. Carter BW. Mediastinal Mass. In: Expert DDx Chest 2. Elsevier, 2020.
31. Carter BW. Chest Wall Mass. In: Expert DDx Chest 2. Elsevier, 2020.
32. Carter BW. Approach to Pulmonary Arteries. In: Expert DDx Chest 2. Elsevier, 2020.
33. Carter BW. Oncology. In: Expert DDx Chest 2. Elsevier, 2020.
34. Carter BW. Approach to Pleura. In: Expert DDx Chest 2. Elsevier, 2020.
35. Carter BW. Chest Wall Mass (Osseous). In: Expert DDx Chest 2. Elsevier, 2020.
36. Carter BW. Diaphragmatic Mass. In: Expert DDx Chest 2. Elsevier, 2020.
37. Carter BW. Ground-glass Opacity. In: Expert DDx Chest 2. Elsevier, 2020.
38. Carter BW. CT Pulmonary Angiography Template. In: Structured Reporting in Radiology. Elsevier, 2019.
39. Carter BW. Mediastinal Cysts. In: Chest Imaging. Rotations in Radiology Series. Oxford University Press, 2019.
40. Carter BW. Glandular Enlargement in the Mediastinum. In: Chest Imaging. Rotations in Radiology Series. Oxford University Press, 2019.
41. Carter BW. Vascular Lesions of the Mediastinum. In: Chest Imaging. Rotations in Radiology Series. Oxford University Press, 2019.
42. Carter BW. Miscellaneous Lesions of the Mediastinum. In: Chest Imaging. Rotations in Radiology Series. Oxford University Press, 2019.
43. Carter BW. Mediastinal Lymphadenopathy. In: Chest Imaging, Rotations in Radiology Series. Oxford University Press, 2019.
44. Shroff GS, Kalhor N, Mehran RJ, de Groot PM, Carter BW. Staging of Small Cell Lung Cancer. In: Diagnostic Imaging for Thoracic Surgery - A Manual for Surgeons and Radiologists. Springer, 175-188, 2018.
45. Carter BW. Approach to Inhalational, Inflammatory, Metabolic and Post-treatment. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
46. Carter BW. Tumor Embolism. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
47. Carter BW. Head-cheese Sign. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
48. Carter BW. Flame-shaped Nodules. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
49. Carter BW. Approach to Small Airways Disease. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
50. Carter BW. Approach to Neoplasms. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
51. Carter BW. Approach to Congenital. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
52. Carter BW. Progressive Systemic Sclerosis. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
53. Carter BW. Approach to Vascular Disease. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
54. Carter BW. Random. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
55. Carter BW. Hematogenous Metastases. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
56. Carter BW. Silicosis & Coal-worker Pneumoconiosis. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
57. Carter BW. Peripheral. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
58. de Groot PM, Rice D, Carter BW. Staging of Malignant Pleural Mesothelioma. In: Diagnostic Imaging for Thoracic Surgery, 2017.
59. Shroff G, Carter BW. Staging of Small Cell Lung Cancer. In: Diagnostic Imaging for Thoracic Surgery, 2017.
60. Carter BW. Ground-glass Attenuation. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
61. Carter BW. Kaposi Sarcoma. In: Specialty Imaging: HRCT. 2nd Edition. Elsevier, 2017.
62. Carter BW. Imaging of the Airways. In: Thoracic Requisites. 3rd Edition, 2016.
63. Carter BW, Marom EM. Imaging of the Mediastinum. In: Mediastinal Lesions, 2016.
64. Carter BW. Myeloma and Plasmacytoma. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
65. Carter BW. Vascular Neoplasms. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
66. Carter BW. Approach to Cardiovascular Neoplasms. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
67. Carter BW. Approach to Other Primary Pulmonary Neoplasms. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
68. Carter BW. Approach to Lung Cancer Staging. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
69. Carter BW. Approach to Imaging Modality: Computed Tomography. In: Specialty Imaging: Thoracic Neoplasms. 1t Edition, 2015.
70. Carter BW. Cardiac Sarcoma. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
71. Carter BW. Lobectomy. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
72. Carter BW. Malignant Tracheobronchial Neoplasms: Sarcomas and Lymphomas. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
73. Carter BW. Approach to Imaging Modalities: PET-MRI. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
74. Carter BW. Osteosarcoma. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
75. Carter BW, Digumarthy SR. Neoplasms of the Lungs and Airways. In: Problem Solving in Chest Imaging. 1st Edition, 2015.
76. Carter BW. Pulmonary Artery Sarcoma. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
77. Carter BW. Imaging of Neurofibromaosis. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
78. Carter BW. Metastatic Lymphadenopathy. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
79. Carter BW. Approach to Other Lung Cancer Issues. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
80. Carter BW. IASLC Lymph Node Map. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
81. Carter BW. Approach to Imaging Modalities: PET-CT. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
82. Carter BW. Approach to Tracheobronchial Neoplasms. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
83. Carter BW. Ewing Sarcoma Family of Tumors. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
84. Carter BW. Approach to Post-Treatment Chest. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
85. Carter BW. Staging of Esophageal Carcinoma. In: Specialty Imaging: Thoracic Neoplasms. 1st Edition, 2015.
86. de Groot PM, Carter BW, Munden RF. Conventional Imaging of Lung Cancer. In: Thoracic Oncology: The IASLC Multidisciplinary Approach. IASLC Press, 293-314, 2014.
87. Lichetenberger JP, Hui G, Carter BW, Jamisdow C, Abbara S. Cardiac Devices. In: Problem Solving in Radiology: Cardiovascular Imaging. Elsevier, 2013.
88. Rojas C, Abbara S, Carter BW. Ventricular Septal Defects. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
89. Carter BW. Pseudocoarctation of the Aorta. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
90. Carter BW. D-Transposition of Great Arteries. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
91. Carter BW, Abbott GF. Pulmonary Sequestration. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
92. Carter BW. Pulmonary Stenosis. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
93. Carter BW, Abbott GF. Pulmonary Arteries. In: Problem Solving in Radiology: Cardiovascular Imaging. Elsevier, 2013.
94. Carter BW. Pulmonary Arterial Hypertension. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
95. Carter BW. Pericardial Effusion. In: Diagnostic Imaging: Cardiovascular. 2nd Edition, 2013.
96. Carter BW, Muse VV, Singh A. Imaging of Nontraumatic Mediastinal and Pulmonary Processes. In: Emergency Radiology: Imaging of Acute Pathologies. Springer, 2013.
97. Abbara S, Walker CM, Carter BW. Cardiac Sarcoma. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
98. Carter BW. Ductus Diverticulum. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
99. Carter BW, Abbott GF. Superior Vena Cava Syndrome. In: Diagnostic Imaging: Emergency. 2nd Edition. Lippincott Williams & Wilkins, 2013.
100. Carter BW. Takayasu Arteritis. In: Diagnostic Imaging: Cardiovascular. 2nd Edition, 2013.
101. Carter BW, Abbott GF. Pulmonary Arteriovenous Malformation. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
102. Carter BW. Pulmonary Atresia. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
103. Carter BW. Branch Pulmonary Artery Stenosis. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
104. Rojas C, Abbara S, Carter BW. Atrial Septal Defects. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
105. Lichtenberger JP, Carter BW, Abbara S. Myocardial Masses. In: Problem Solving in Radiology: Cardiovascular Imaging. Elsevier, 2013.
106. Carter BW. Truncus Arteriosus. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
107. Carter BW, Abbott GF. Superior Vena Cava Obstruction. In: Diagnostic Imaging: Cardiovascular. 2nd Edition. Lippincott Williams & Wilkins, 2013.
108. Carter BW. Pulmonic Stenosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
109. Abbott GF, Carter BW. Solid Pleural Metastases. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
110. Abbott GF, Carter BW. Middle Lobe Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
111. Abbott GF, Carter BW. Left Lower Lobe Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
112. Carter BW. Lymphadenopathy, Metastatic Disease. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
113. Abbott GF, Carter BW. Malignant Pleural Mesothelioma. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
114. Abbott GF, Carter BW. Right Lower Lobe Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
115. Carter BW. Strongyloidiasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
116. Carter BW. Pulmonary Wegener Granulomatosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
117. Carter BW. Cryptococcosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
118. Carter BW. Mediastinal Vascular Masses. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
119. Abbott GF, Carter BW. Aortic Valve Disease. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
120. Carter BW. Pulmonary Artery Sarcoma. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
121. Carter BW. Atrial Septal Defect. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
122. Abbott GF, Carter BW. Left Atrial Calcification. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
123. Abbott GF, Carter BW. Lymphangioleiomyomatosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
124. Abbott GF, Carter BW. Cicatricial Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
125. Carter BW. Acute Respiratory Distress Syndrome. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
126. Carter BW. Takayasu Arteritis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
127. Abbott GF, Carter BW. Subsegmental Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
128. Abbott GF, Carter BW. Fat Embolism. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
129. Carter BW. Polymyositis/Dermatomyositis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
130. Martinez-Jimenez S, Carter BW. Acute Aortic Syndrome. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
131. Abbott GF, Carter BW. Relaxation and Compression Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
132. Carter BW. Neurofibromatosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
133. Abbott GF, Carter BW. Coronary Artery Calcification. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
134. Abbott GF, Carter BW. Complete Lung Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
135. Carter BW. Ventricular Septal Defect. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
136. Carter BW. Mediastinal Fibrosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
137. Abbott GF, Carter BW. Rounded Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
138. Abbott GF, Carter BW. Noncardiogenic Pulmonary Edema. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
139. Carter BW. Castleman Disease. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
140. Abbott GF, Carter BW. Saber Sheath Trachea. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
141. Carter BW. Lobectomy. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
142. Carter BW. Cardiac Sarcoma. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
143. Abbott GF, Carter BW. Laryngeal Papillomatosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
144. Abbott GF, Carter BW. Left Upper Lobe Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
145. Abbott GF, Carter BW. Pulmonary Artery Hypertension. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
146. Abbott GF, Carter BW. Valve and Annular Calcification. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
147. Carter BW. Lymphadenopathy, Sarcoidosis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
148. Abbott GF, Carter BW. Ventricular Calcification. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
149. Carter BW. Absence of the Pericardium. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
150. Abbott GF, Carter BW. Right Upper Lobe Atelectasis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
151. Carter BW. Plasmacytoma and Multiple Myeloma. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
152. Abbott GF, Carter BW. Superior Vena Cava Obstruction. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
153. Abbott GF, Carter BW. Constrictive Bronchiolitis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.
154. Abbott GF, Carter BW. Infectious Bronchiolitis. In: Diagnostic Imaging: Chest. 2nd Edition. Lippincott Williams & Wilkins, 2012.

Books (edited and written)

1. Rosado-de-Christenson ML, Martinez-Jimenez S, Carter BW, Lichtenberger JP III, Frazier A, Heeger A, Restrepo C, Claudio SFA, Carillo-Bayona JA, Garran S, Betancourt S, Ternes T, Fuss C. Diagnostic Imaging: Chest. Ed(s) 3rd Edition. Elsevier, 2022.
2. Carter BW, Rosado de Christenson ML, Lichtenberger JP III. Expert DDx Chest. Ed(s) 2nd Edition. Elsevier, 2020.
3. Martinez-Jimenez S, Rosado de Christenson ML, Carter BW. Specialty Imaging: HRCT. Ed(s) 1st Edition. Elsevier, 2017.
4. Abbara S, Kim R, Achenbach S, Carter BW, Walker CM, Dodd JD, Walker TG, Chung JH, Kalva SP, Martinez-Jimenez S, Wu CC, Lichtenberger III JP, Ganguli S. Diagnostic Imaging: Cardiovascular. Ed(s) 2nd Edition. Lippincott Williams & Wilkins, 2013.
5. Rosado de Christenson ML, Carter BW, et al. Specialty Imaging: Thoracic Neoplasms. Ed(s) 1st Edition. Lippincott Williams & Wilkins, 2013.
6. Rosado-de-Christenson ML, Abbott GF, Martinez-Jimenez S, Healey T, Chung JH, Wu CC, Carter BW, Lichtenberger JP III, Winer-Muram H, Kanne J, Franquet T, Ternes T, Strollo D. Diagnostic Imaging: Chest. Ed(s) 2nd Edition. Lippincott Williams & Wilkins, 2012.